fluconazole and ketoconazole

fluconazole has been researched along with ketoconazole in 570 studies

Research

Studies (570)

TimeframeStudies, this research(%)All Research%
pre-199052 (9.12)18.7374
1990's217 (38.07)18.2507
2000's159 (27.89)29.6817
2010's120 (21.05)24.3611
2020's22 (3.86)2.80

Authors

AuthorsStudies
Algueró, M; Bartroli, J; Boncompte, E; Forn, J; García-Rafanell, J; Turmo, E; Vericat, ML1
Kukla, MJ; Liu, L; Marichal, P; Odds, F; Saha, AK; Simoneaux, RL1
Buchta, V; Fáková, H; Koudelka, P; Kubanová, P; Pour, M; Pourová, H; Schiller, R; Spulák, M; Voprsalová, M; Wsól, V1
Casciano, CN; Clement, RP; Johnson, WW; Lew, K; Wang, EJ1
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K1
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K1
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK1
Artico, M; D'Auria, FD; De Martino, G; Di Pasquali, A; La Regina, G; Nencioni, L; Palamara, AT; Silvestri, R1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ji, H; Jiang, Q; Lü, J; Miao, Z; Sheng, C; Song, Y; Xu, H; Yao, J; Zhang, M; Zhang, W; Zhou, Y; Zhu, J1
Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P1
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL1
Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH1
Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ1
Kang, TH; Kim, S; Park, JS; Suh, YG; Yu, KA1
Alvarado-Ramírez, E; Torres-Rodríguez, JM1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA1
Chaffin, WL; Mekala, S; Perumal, P1
Herrmann, JV; Miltenberger, R; Müller, FM; Salvenmoser, S; Staudigel, A; Tredup, A1
Calderone, R; Chauhan, N; Kruppa, M1
Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J1
Acimovic, J; Kocjan, D; Korosec, T; Rozman, D; Seliskar, M; Tacer, KF; Urleb, U1
Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA1
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL1
Agarwal, AK; Ashfaq, MK; Babu, KS; Clark, AM; Elsohly, HN; Jacob, MR; Khan, SI; Li, XC; Manly, SP1
Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S1
Artico, M; Botta, M; Caporuscio, F; Cirilli, R; D'Auria, FD; De Melo, NR; Kelly, SL; La Regina, G; La Torre, F; Lamb, DC; Nencioni, L; Olla, S; Palamara, AT; Piscitelli, F; Silvestri, R; Tafi, A1
Kelly, DE; Kelly, SL; Manning, NJ; Merkamm, M; Parker, JE; Pompon, D1
Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P1
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD1
Jackson, CJ; Kelly, DE; Kelly, SL; Lamb, DC; Marczylo, TH; Parker, JE; Warrilow, AG1
Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J1
Aher, NG; Bhat, MK; Kumar, A; Mishra, NN; Pore, VS; Sharma, A; Shukla, PK1
Pratim Roy, P; Roy, K1
Cheng, A; Lou, H; Sun, L; Sun, S; Wu, X; Zhang, Y1
Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A1
Rahkhoodaee, F; Raymond, M; Tsao, S1
Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y1
Bergès, T; Bouchara, JP; Chabasse, D; Renier, G; Rocher, F; Tronchin, G; Vandeputte, P1
Cenci, E; Costantino, G; Fringuelli, R; Giacchè, N; Macchiarulo, A; Milanese, L; Schiaffella, F; Vecchiarelli, A1
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Kumar, A; Mathew, BP; Nath, M; Sharma, S; Shukla, PK1
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Aytemir, MD; Ozçelik, B1
Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y1
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M1
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, X; Lin, X; Skolnik, S; Wang, J1
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C1
Arun, Y; Balachandran, C; Bhaskar, G; Perumal, PT; Saikumar, C1
Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Emami, S; Faramarzi, MA; Irannejad, H; Samadi, N; Shojapour, S1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chai, X; Ding, H; Li, L; Wang, B; Wu, Q; Yu, S; Zou, Y1
Chai, X; Hu, H; Huang, T; Li, R; Li, X; Wu, M; Wu, Q; Yu, S; Zhao, Q; Zou, Y1
Gerwick, WH; Kurtán, T; Liu, B; Mándi, A; Sun, P; Tang, H; Wang, ZW; Xu, DX; Zhang, W1
Arul Antony, S; Balachandran, C; Shahavar Sulthana, S; Syed Shafi, S1
Kheylik, Y; Kondratov, I; Krasavin, M; Naumchyk, V; Platonov, M; Zahanich, I; Zozulya, S1
Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD1
Akdemir, A; Bizzarri, B; Bolasco, A; Caprara, F; Carradori, S; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zicari, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, F; Di, H; Lan, L; Li, J; Lu, Y; Sheng, C; Wang, X; Wang, Y; Wei, H; Xiao, Q; Xu, Y; Zhang, L; Zhu, J1
Aktumsek, A; Bizzarri, B; Carradori, S; Chimenti, P; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zengin, G; Zicari, A1
Chen, F; Di, H; Lan, L; Li, J; Lu, Y; Wang, X; Wang, Y; Wei, H; Xiao, Q; Xu, Y; Zhang, L; Zhu, J1
Carazo, A; Drechslerová, M; Hrušková, ZR; Hyrsova, L; Kuneš, J; Nova, A; Pavek, P; Pour, M; Smutny, T; Špulák, M1
Kovalenko, A; Krasavin, M; Lukin, A; Moore, D; Tikhonova, IG; Zahanich, I; Zhurilo, N; Zozulya, S1
Cheng, M; Hao, C; Liu, C; Su, X; Sun, B; Wei, P; Zhang, X; Zhao, D; Zhao, L; Zhao, S1
Cai, Z; Ding, Z; Jiang, Y; Jin, Y; Li, R; Ni, T; Pang, L; Wang, T; Xie, F; Yu, S; Zhang, D; Zhao, J1
Cheng, M; Hao, C; Liu, C; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S1
Chen, F; Chen, W; Hu, L; Lan, L; Li, B; Li, J; Li, X; Lin, D; Liu, W; Liu, Y; Lu, Y; Mao, F; Ni, S; Qiu, X; Wang, M; Wei, H; Xu, Y; Zheng, X; Zhu, J1
Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J1
Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL1
Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G1
Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C1
Breckenridge, A1
Gedde, S; Head, WS; O'Day, DM; Robinson, RD; Williams, TE1
Bodey, GP1
Wheat, LJ1
Denning, DW; Graybill, JR; Hanson, LH; Pappagianis, D; Rinaldi, MG; Sharkey, PK; Stevens, DA; Tucker, RM1
Baran, R1
Van Cutsem, J1
Viviani, MA1
Basugi, N; Eguchi, M; Matsuno, A; Yoshida, S1
Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P1
Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS1
Lesher, JL1
Bava, AJ; Negroni, R1
Bender, HG; Laufer, B1
Büchner, T; Roos, N1
Lode, H; Schaberg, T1
Lozano, MC; Martín, E; Parras, P1
Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P1
Konishi, H; Morita, K; Shimakawa, H1
Bennett, DE; Coleman, DC; Flint, SR; Gallagher, PJ; Henman, MC; Russell, RJ; Shanley, DB1
Chan, YF; Morris, B; Reddy, J; Woodgyer, A1
Dayer, P; Leemann, T1
Georgiev, VS1
Arena, V; Bresadola, M; Cipriani, P; Cirillo, L; Donadio, C; Ghezzi, C; Mazziotti, F; Pellizzari, G; Ragni, N1
Coker, RJ; Harris, JR; Main, J; Moulopoulos, D; Murphy, SM; Pinching, AJ1
Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Yarosh-Tomaine, T1
Gibaldi, M2
Chandrasekar, PH; Edwards, DJ; Milad, MA; Touchette, MA1
Ehninger, G; Jaschonek, K; Pawelec, G; Rehbein, A; Schaudt, K1
Durmaz, B1
Lamey, PJ; Lewis, MA; Samaranyake, LP1
Ancarani, F; Arzeni, D; Barchiesi, F; Scalise, G1
Back, DJ; Tjia, JF1
Ehninger, G; Jaschonek, K; Pawelec, G1
Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB1
Borowski, E; Mignini, F; Milewski, S1
Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W1
Brettle, RP; Leen, CL; Milne, LJ; Russell, TB; Urquhart, D; Willocks, L1
Goto, S; Kawasaki, K; Matsumura, Y; Matsunaga, T; Ogawa, M; Tsuji, A1
Collett, MG; Henton, M; Lambrechts, N1
Fernandez, M; Zar, FA1
Costa, AR; Cucé, LC; dos Reis, VM; Lacaz, Cda S; Müller, H; Pegas, JR; Pires, MC; Porto, E; Rodrigues, MC1
Piérard, GE; Piérard-Franchimont, C; Rurangirwa, A1
Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L1
Graybill, JR; Sharkey, PK1
Cauwenbergh, G; Heykants, J; Lavrijsen, K; Meuldermans, W; Van Peer, A; Woestenborghs, R1
Shindo, K1
Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM1
Blum, RA; D'Andrea, DT; Florentino, BM; Gardner, MJ; Goldstein, H; Henry, EB; Hilligoss, DM; Schentag, JJ; Wilton, JH1
Dettori, G; Manzara, S; Morace, G1
Ellis, ME; Fox, R; Leen, CL; Mandal, BK; Neal, KR1
Harris, JR; Kitchen, VS; Savage, M1
Bercy, P; De Beule, F; Ferrant, A1
Brummer, E; Hanson, LH; Stevens, DA1
Bastide, JM; Mallié, M; Montès, B; Reynes, J1
Coker, DM; Kinghorn, GR; O'Mahony, C; Talbot, MD; Woolley, PD1
Ringel, SM1
Hector, RF; Yee, E1
Defaveri, J; Graybill, JR; Sun, SH1
Bailey, EM; Krakovsky, DJ; Rybak, MJ1
Linde, I; Mattie, H; Meynaar, I; Poell, R; Van 't Wout, JW; Van Furth, R1
Guinet, R; Marlier, H1
Larsen, RA1
Perfect, JR; Ritter, W; Wright, KA1
Meunier, F1
Ballard, SA; Ellis, SW; Kelly, SL; Troke, PF2
Mai, GT; McCormack, JG; Seow, WK; Thong, YH; Vuddhakul, V1
Mathiesen, LR; Thorsen, S1
Bottino, G; Menna, C1
Bergerat, JP; Dufour, P; Herbrecht, R; Koenig, H; Liu, KL; Maloisel, F; Oberling, F; Waller, J1
Kawasaki, K; Matsunaga, T; Uchida, K; Yamaguchi, H1
Dupont, B2
Mattie, H; van Furth, R; Van t Wout, JW1
Martin, MV1
Charuel, C; Latrille, F; Lodola, A1
Kobayashi, GS; Spitzer, ED1
Graybill, JR1
Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D1
Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F1
Warnock, DW1
Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P1
Bligh, HF; Kelly, SL; Kenna, S; Watson, PF1
Ehninger, G; Einsele, H; Jaschonek, K; Roth, HJ; Steinhilber, D1
Coussement, W; De Coster, R; Lampo, A; Marsboom, R; Van Cauteren, H; Vandenberghe, J; Vanparys, P1
Clumeck, N; De Wit, S; Goossens, H; Weerts, D1
Polak, A1
Houston, JB; Humphrey, MJ; Matthew, DE; Tarbit, MH1
Dismukes, WE; Saag, MS1
Walsh, TJ1
Beggs, WH; Bennett, RL; Hughes, CE; Tuna, IC1
Senior, DS; Shaw, JT1
Abadie, SM; Greer, DL; Noel, SB; Pankey, GA; Zachary, JA1
Dismukes, WE1
Hanger, DP; Jevons, S; Shaw, JT1
Coulaud, JP; Ngo Van, P1
Drew, RH; Gallis, HA; Perfect, JR1
Pizzo, A; Walsh, TJ1
Gordon, MA; Lapa, EW; Passero, PG1
Beach, DH; Goad, LJ; Holz, GG1
Bähr, V; Eckhoff, C; Oelkers, W1
Odds, FC; Webster, CE1
Faergemann, J1
Brammer, KW; Feczko, JM1
Hay, RJ2
Stevens, DA1
Brammer, KW; Kutzer, E; Leodolter, S; Oittner, R1
Brammer, KW; Marriott, MS; Richardson, K; Troke, PF1
Durack, DT; Perfect, JR1
Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF1
Durack, DT; Perfect, JR; Savani, DV1
Ahrens, J; Graybill, JR; Sun, SH1
Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW1
Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH1
Ahrens, J; Graybill, JR; Palou, E1
Galgiani, JN; Rogers, TE1
Cobo, LM; Durack, DT; Perfect, JR; Savani, DV1
Beggs, WH; Hughes, CE1
Dixon, DM; Polak, A1
Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF1
Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA1
Asgari, M; Back, DJ1
Wenig, JA1
Just-Nübling, G1
Staben, C1
Baldwin, BC; Corran, A; Kelly, SL; Kwon-Chung, J; Lamb, DC1
Hahn, K; Scheven, Ch; Scheven, M; Senf, A1
Denning, DW1
Hoeprich, PD1
Ahearn, DG; Kalya, AV1
Bernhardt, R; Denner, K; Doehmer, J; Schmalix, W; Vogel, R1
Force, RW; Nahata, MC1
Cross, JT; Hickerson, SL; Yamauchi, T1
Barchiesi, F; Colombo, AL; McGough, DA; Rinaldi, MG1
Johnson, EM; Luker, J; Porter, SR; Scully, C; Warnock, DW1
Denning, DW; Law, D; Mason, C; Moore, CB; Wardle, HM1
Belcher, KE; Law, EJ; Spencer, SA; Still, JM1
Andreu, A; Arévalo, MP; Arias, A; Rodríguez, C; Sierra, A1
Acosta, D; Rodriguez, RJ2
Greenspan, D1
Wheat, J1
Kivistö, KT; Klotz, U; Neuvonen, PJ1
Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G1
Bartlett, MS; Queener, SF; Richardson, JD; Shaw, MM; Smith, JW1
Galimberti, R; Robles-Soto, M; Stengel, F; Suchil, P1
Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B1
Hernández-Sampelayo, T1
DeDoncker, PR; Degreef, HJ1
Roberts, DT1
Bickers, DR1
al Khayat, R; Courdavault, L; Michel, C; Mignon, F; Roux, P; Viron, B1
Aoki, Y; Arisawa, M; Kondoh, M; Nakamura, Y; Nakayama, N; Yoshihara, F1
Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F1
Cantilena, LR; Honig, PK1
Bailey, CJ; Cartledge, JM; Morris, SA1
Arendorf, TM; van der Bijl, P1
Edwards, JE; Filler, SG; Swerdloff, JN1
Dodd, CL; Greenspan, D; Heinic, GS; Hollander, H; MacPhail, LA; Stevens, DA; Stringari, S; Strull, WM1
Drew, RH1
Baciewicz, AM; Baciewicz, FA1
Neely, D1
Sangueza, OP; Shupack, JL; Stiller, MJ1
Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F1
Johnson, EM; Warnock, DW; White, DJ1
Fetchick, R; Graybill, JR; Sharkey-Mathis, PK; Velez, J1
Klauss, V; Lund, OE; Miño de Kaspar, H1
Degreef, H1
Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV1
Brossier, KA; Goldschmidt, RH; Legg, JJ1
Rutledge, TM; Thio, CL1
Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E1
Johnson, EM; Warnock, DW1
Kalhorn, TF; Kharasch, ED; Mitra, AK; Slattery, JT; Thummel, KE; Unadkat, JD1
Cunha, BA; Klein, NC1
Chen, SC; Gilbert, GL; Gordon, S; O'Donnell, ML1
Brennan, B; Ervine, CM; Houston, JB; Matthew, DE1
Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH1
Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Smith, JG1
Clark, FS; Gow, NA; Hitchcock, CA; Parkinson, T1
Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU1
Gill, HJ; Madden, S; Maggs, JL; Park, BK; Pirmohamed, M1
Caldarola, G; Cauda, R; Morace, G; Ortona, L; Posteraro, B; Tacconelli, E; Tumbarello, M1
Bunting, P; Finlay, R; Richardson, C; Taylor, CB; Welch, J1
Moreno, MI; Zaror, L1
Goldman, M; Lee, YP1
Cao, B; Samaranayake, LP; Tsang, DN; Tsang, PW; Wang, J1
Friedman, HL; Greenblatt, DJ; Karsov, D; Schmider, J; Shader, RI; Vena, R; von Moltke, LL1
Baldwin, BC; Corran, AJ; Kelly, DE; Kelly, SL; Lamb, DC1
Kelly, DE; Kelly, SL; Lamb, DC; Manning, NJ1
Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J1
Gøtzsche, PC; Johansen, HK1
McDonald, JA; Saulsbury, FT1
Carver, PL; Kauffman, CA1
Baily, GG; Denning, DW; Hood, SV1
Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK1
White, TC1
Cartledge, JD; Gazzard, BG; Midgley, J2
Burke, MD; Hawksworth, GM; Humphrey, MJ; Omar, G; Whiting, PH1
Mayer, P; Quivey, J; Ramirez-Amador, V; Silverman, S; Tyler, M1
Evans, S; Leake, H; Ustianowski, AP1
Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U1
Hecker, D1
Cartledge, JD; Gazzard, BG; Midgley, J; Petrou, M; Shanson, D1
Bone, WD; Gray, GC; Martin, CR; Oldfield, EC; Olson, P; Schillaci, RF1
Klimke, K; Schäfer-Korting, M1
Hofmann, H; Metzger, S1
Burgaleta, C1
Bouza, E; Muñoz, P1
Fortun Abete, J1
Hernanz Hermosa, JM; Lázaro Ochaita, P1
Odds, FC1
Berenguer Berenguer, J1
Casali, AK; Hamdan, JS1
Kadowaki, K; Komaki, H; Mikami, Y; Tanaka, Y; Thomson, KS; Yazawa, K1
Andrew, SE; Brooks, DE; Dillavou, CL; Ellis, G; Kubilis, PS1
Brettle, RP; Laing, RB; Leen, CL1
Chapman, SW; Rinaldi, MG; Rogers, PD; Sullivan, DC1
Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H1
Demitrovicova, A; Kralovicova, K; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Mrazova-Studena, M; Oravcova, E; Spanik, S; Stopkova-Grey, K; Trupl, J1
Elewski, BE1
Ellepola, AN; Samaranayake, LP6
McLachlan, AJ; Tett, SE1
Arceneaux, KA; Hosgood, G; Taboada, J1
Cihlar, RL; McElhaney-Feser, GE; Raulli, RE1
Nguyen, MH; Yu, CY1
Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A1
Counihan, M; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Mertzanis, P; Roth-Schechter, B; Shader, RI; von Moltke, LL1
Burattini, MN; Colombo, AL; Costa, PR; Fischmann, O; Kallás, EG; Milan, EP1
Araj, GF; Daher, NK; Tabbarah, ZA1
Gibbs, MA; Kunze, KL; Shen, DD; Thummel, KE1
Berrouane, YF; Herwaldt, LA; Pfaller, MA1
Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M1
Terrell, CL1
Frieden, IJ; Howard, RM1
Ha, KC; White, TC1
Liang, D; Lu, Y; Zhang, H1
Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z1
Bouchara, JP; Chabasse, D; Declerk, P; Defontaine, A; Hallet, JN; Planchenault, C1
Ambroise-Thomas, P; Brion, JP; Grillot, R; Lebeau, B; Pavese, P1
Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K1
Bonnabry, P; Dayer, P; Leemann, T; Sievering, J1
Didmon, M; Favre, B; Ryder, NS1
Alonso-Vargas, R; Arévalo, P; Bornay-Llinares, FJ; Carrillo-Muñoz, AJ; del Valle, O; Gasser, I; Quindós, G; Ruesga, MT; Santos, P; Tur-Tur, C1
Astoul, P; Bérard, H; Boutin, C; Cho, K; Cuguillière, A; Frenay, C1
Korting, HC; Niewerth, M1
Chang, HC; Chang, JJ; Chang, TC; Huang, AH1
Iga, T; Kawakami, J; Sato, H; Sawamura, R1
Hahn, RC; Hamdan, JS1
Ringdahl, EN1
Del Rosso, JQ; Gupta, AK1
Igarashi, T; Ishiguro, N; Kishimoto, W; Sakai, K; Senda, C; Takano, J1
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B1
Smith, EB1
Kibbler, CC; McWhinney, PH; Paterson, PJ; Potter, M; Prentice, HG1
García, MT; Llorente, MT; Mínguez, F; Prieto, J2
Birinci, A; Durupinar, B; Saniç, A1
Bodey, GP; Chatzinikolaou, I; Hajiioannou, I; Kontoyiannis, DP; Maraki, S; Rolston, KV; Samonis, G1
Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA1
Iyer, RR; Iyer, SR1
Busowski, JD; Safdar, A1
King, S; McGeer, A; Richardson, S; Walmsley, S; Ye, Y1
Barr, D; Smart, T1
Brooks, JT; Wheat, LJ1
Briand, V; Lortholary, O1
Samaranayake, LP; Samaranayake, YH; Tsang, PC; Wong, KH; Yeung, KW1
Bonito, AJ; Patton, LL; Shugars, DA1
Crego, AL; Gómez, J; Lavandera, JL; Marina, ML1
Anil, S; Ellepola, AN; Samaranayake, LP1
Feng, XT; Liu, CM; Ma, MC; Wu, YJ; Zhang, DZ; Zhou, TS1
Torres-Rodríguez, JM; Vivas, JR1
Bruserud, O1
Arrese, JE; Piérard, GE; Piérard-Franchimont, C1
Baruah, MC; Bhogal, CS; Singal, A1
Kantarjiev, TB; Kuzmanov, AH; Zissova, LG1
Alcântara, AP; Carvalho, MT; Colombo, AL; Ferreira, MS; Martinez, R; Milan, EP; Queiroz-Telles, F; Sant'Ana, Pde L1
Farschian, M; Samadi, K; Yaghoobi, R1
Capilla, J; Fernández-Torres, B; Guarro, J; Ortoneda, M; Pujol, I1
Alvarado, D; Díaz, MC; Silva, V2
Bhoopathy, S; Karnes, HT; Sarkar, MA1
Abdel-Moety, EM; AbouAl-Alamein, AM; Kelani, KM; Khattab, FI1
Ergon, C; Ozkutuk, A; Yulug, N1
Engelen, M; Rochette, F; Vanden Bossche, H1
Nikkels, AF; Piérard, GE1
Usatine, RP1
del Palacio, A; Garau, M; Pereiro, M1
Alvareda, D; Silva, V; Zepeda, G1
Daneshtalab, M; Kurosawa, T; Mori, Y; Sardari, S1
Gupta, AK; Ryder, JE1
Fehér, J; Lengyel, G1
Bansal, AK; Garg, P; Gopinathan, U; Mahesh, S; Rao, GN1
González-Monroy, J; Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ1
Bliss, JM; Gigliotti, F; Wellington, M1
Gangneux, JP; Guiguen, C; Preney, L; Théraud, M1
Junnu, V; Suvoutho, S; Tiewcharoen, S1
Maertens, JA1
Seebacher, C1
Al Hedaithy, SS; Fotedar, R1
Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B1
Marrazzo, J1
Spence, D2
Chen, CG; Lo, HJ; Shih, HI; Su, CL; Yang, YL1
Antal, Z; Dóczi, I; Dósa, E; Kredics, L; Nagy, E; Varga, J1
Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V1
Chen, X; Hiruma, M; Ogawa, H; Shiraki, Y1
Chimishkian, KL; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV1
Yasuda, MA1
Ayangil, D; Cankaya, S; Ferahbaş, A; Koc, AN; Silici, S1
Suh, MK1
Abbasoglu, U; Kalkanci, A; Kaynak, F; Kustimur, S; Ozkan, S1
Ayala-Lugo, R; Barbosa, L; de Kaspar, HM; Sanchez-Di Martino, D; Sonego-Krone, S; Ta, CN; Torres-Alvariza, G1
Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM1
Niwa, T; Shiraga, T; Takagi, A1
Abramowitz, W; Jakate, AS; Kapil, R; Patel, A; Persiani, S; Roy, P; Wangsa, J1
Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW1
Berman, J1
Hector, RF1
Craig, JC; Playford, EG; Sorrell, TC; Webster, AC1
Luger, A; Maier, C; Nowotny, P; Riedl, M; Schima, W; Zettinig, G1
Crawford, F; Ferrari, J2
Das, H; Deb, M; Khanal, B; Kumar, S; Panda, A1
Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST1
Bramson, C; Gardner, M; Milton, A; Ouellet, D; Randinitis, E; Remmers, AE; Roman, D1
Rott, T; Rylander, R; Tercelj, M1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Barros, ME; Hamdan, JS; Santos, Dde A1
Antaya, RJ; Davis, A; Imaeda, S; Kiken, DA; Sekaran, A; Silverberg, NB1
Bagyalakshmi, R; Deepa, P; Madhavan, HN; Therese, KL1
Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS1
Brocks, DR; El-Kadi, AO; Korashy, HM; Shayeganpour, A1
Pagano, R1
da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J1
Chen, FC; Lin, M1
Gupta, A; Mao, Q; Unadkat, JD1
de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA1
Azizi, H; Suizi, B; Yazdanpanah, MJ1
Korting, HC; Schmid-Wendtner, MH1
Brown, HS; Chadwick, A; Houston, JB1
Brocks, DR; El-Kadi, AO; Korashy, HM1
Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P1
Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ; Millan-Chiu, B; Mondragón-González, R; Velásquez-Hernández, V1
Buhl, M; Christensen, S; Tønnesen, EK1
Boulenc, X; Hachad, H; Levy, RH; Ragueneau-Majlessi, I; Rauch, C1
Bobrov, VI; Borisov, MM; Ptitsina, SN1
Korhonen, T; Laine, K; Pelkonen, O; Tolonen, A; Turpeinen, M1
Balci, DD; Cetin, M1
Barker, S; Essmann, M; Larsen, B; Schmidt, M1
Campbell, B; Chan, K; Kim, J; Mahoney, N; May, G; Molyneux, R1
Chandrasekhar, MR; Chunchanur, SK; Halesh, LH; Nadagir, SD; Patil, BS; Yasmeen, K1
Perheentupa, J; Pfaller, M; Rautemaa, R; Richardson, M; Saxen, H1
Anderson, R; Steel, HC; Tintinger, GR1
Ajdary, S; Amirkhani, A; Bassiri Jahromi, S; Eslamifar, A; Katiraee, F; Khaksar, AA; Paskiabi, FA; Sadeghi, G; Sayyah, M; Taeb, J1
Nawrot, U; Nowicka, J; Wlodarczyk, K1
Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M1
Cruz, AR; Gallin, JI; Huang, CY; Zarember, KA1
Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F1
Ambudkar, SV; Gaur, M; Prasad, R; Puri, N; Sharma, M; Shukla, S1
Billack, B; Lau-Cam, C; Santoro, M1
Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S1
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S1
Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S1
Balani, SK; Ducray, PS; Lu, C; Prakash, SR; Qian, MG; von Moltke, LL1
Aala, F; Alizadeh, F; Chong, PP; Khodavandi, A; Sekawi, Z1
Fick, J; Lindberg, RH; Tysklind, M1
Millikan, LE1
Aijaz, A; Amber, K; Immaculata, X; Luqman, KA; Nikhat, M1
Ayadi, A; Ben Salah, H; Boudaya, S; Chikrouhou, F; Makni, F; Masmoudi, A; Turki, H1
Elliot, DJ; Janchawee, B; Miners, JO; Raungrut, P; Somogyi, AA; Uchaipichat, V1
Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG1
Heeres, J; Lewi, P; Meerpoel, L1
Billodre, RG; Heidrich, D; Landell, MF; Scroferneker, ML; Sorrentino, JM; Stopiglia, CD; Vainstein, MH; Valente, P1
Calahorra, M; Lozano, C; Peña, A; Sánchez, NS1
Hosgood, G; Merchant, S; Sickafoose, L; Snook, T; Westermeyer, R1
Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY1
Prasad, R; Sharma, M1
Al-Nawas, B; Karbach, J; Walter, C1
Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D1
Pickova, J; Vestergren, AS; Zamaratskaia, G; Zlabek, V1
Huang, Q; Peng, X; Wang, C; Wang, Z; Yu, Y; Zhang, K1
Chen, TC; Chen, YC; Chen, YH; Lu, PL1
Hu, C; Li, S; Sun, X; Zhang, H; Zhang, X; Zhang, Y; Zhang, Z1
Bielecki, J; Jagielski, T; Kwiatkowski, S; Zak, I1
Chang, W; Cheng, A; Li, Y; Liu, Y; Lou, H; Zhang, L1
Arlt, W; de Herder, WW; de Jong, FH; Feelders, RA; Hofland, J; Hofland, LJ; Steenbergen, J; Taylor, AE; van der Pas, R; van Koetsveld, PM1
Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG1
Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC1
Gärtner, P; Knoth, H; Petry, T1
Gude, T; Kulkarni, MM; McGwire, BS; Reddy, N1
Helou, J; Maatouk, I; Moutran, R; Obeid, G1
Buchbjerg, JK; Chen, G; Højer, AM; Lee, R; Serenko, M; Zhao, Z1
Li, S; Liu, J; Sun, X; Wang, K; Xie, B; Yu, X; Zhang, H; Zhou, F1
Namiki, N; Tanaka, S; Uchida, S1
Chandy, R; Ellepola, AN; Khan, ZU1
Chen, X; Gao, R; Pang, X; Zhang, Y; Zhong, D; Zhong, K1
Bandara, HM; Ellepola, AN; Joseph, BK; Khan, ZU; Samaranayake, LP1
Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Yeung, KW1
Al-Hakami, AM; Assiry, AM; Assiry, MM; Hamid, ME; Jamil, AS; Joseph, MR; Shaker, MA1
Chandra, R; Puri, SK1
Fraczkiewicz, G; Shi, JG; Williams, WV; Yeleswaram, S1
Boysen, S; Letendre, JA1
Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS1
Ellepola, AN; Jayathilake, JA; Khan, ZU; Sharma, PN1
Duarte, MA; Greatti, VR; Lima, FL; Vivan, RR; Weckwerth, PH1
Bulanda, M; Jagielski, T; Skóra, M1
Chen, X; Jin, C; Li, S; Liu, H; Sun, X; Wang, K; Zhang, Z1
Akiyama, K; Kakinuma, Y; Kawahara, R; Kawano-Kawada, M; Pongcharoen, P; Sekito, T; Yamasaki, T; Yasuda, M1
Caraballo-León, J; Mora-Navarro, C; Ortiz-Bermúdez, P; Torres-Lugo, M1
Coors, A; Kunkel, U; Richter, E; Roller, E; Ternes, TA1
Arthanari, H; Bhyravabhotla, J; Boeszoermenyi, A; Buhrlage, SJ; Gelev, V; Gray, NS; Ji, F; Mukherjee, G; Näär, AM; Nishikawa, JL; Posteraro, B; Sadreyev, RI; Sanglard, D; Sanguinetti, M; Sohn, YJ; Torelli, R; Vale-Silva, LA; Wagner, G1
Charoo, NA; Cristofoletti, R; Dressman, JB1
Alves, GS; Bentes, Ados S; de Souza, JV; Freire, AK; Jackisch-Matsuura, AB; Matsuura, T; Pinheiro, JF; Wanke, B1
Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AG1
Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M1
Holman, TR; Hughes, DD; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Smyrniotis, CJ; Thoss, V; Warrilow, AG1
Amano, N; Funami, M; Hirabayashi, H; Iwasaki, S1
Badri, T; Bzioueche, N; Hammami, H; Mokhtar, I; Zouari, B1
Araújo de Medeiros, AC; Cardoso, GN; de Oliveira Lima, E; de Oliveira Lima, MI; de Oliveira Pereira, F; Souza Silva, KV1
Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AGS; Wiederhold, NP1
Abbasi, SA; Bokhari, H; Hussain, Z; Imran, M; Jamil, B; Khalid, T; Mukhtar Bokhari, MT; Mukhtar Bokhari, MZ; Saeed, A1
Lazarin-Bidóia, D; Nakamura, CV; Peron, F; Rodrigues-Filho, E; Silva, SO; Ud Din, Z; Ueda-Nakamura, T1
Amano, N; Hirabayashi, H; Iwasaki, S1
Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S1
Belazarian, L; Levin, NA; Prindaville, B; Wiss, K1
Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG1
Kamata, H; Kano, R; Kariya, N; Oshimo, K; Yokoi, S1
Aguiar, L; Araújo, GDS; Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; España, JDA; Guedes, GMM; Oliveira, JS; Paiva, MAN; Pereira-Neto, WA; Pinheiro, AQ; Rocha, MFG; Rocha, MGD; Sales, JA; Sidrim, JJC1
Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD1
Gammon, G; Kankam, M; Li, J; Trone, D1
Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X1
Hay, RJ; Jemec, GBE; Saunte, DML; Taudorf, EH1
Elgaard, C; Kretschmann, AC; Munkboel, CH; Olesen, MK; Rasmussen, TB; Styrishave, B1
Mandras, N; Roana, J; Scalas, D; Tullio, V1
Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K1
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K1
Cai, T; Chen, Z; Liao, Y; Qiu, X; Zhu, Y1
Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M1
Aneke, CI; Cafarchia, C; Otranto, D; Rhimi, W1
Arturo-Rojas Jiménez, E; Garzón, J; Monroy-Pérez, E; Paniagua-Contreras, GL; Rodríguez-Bedolla, RM; Vaca-Paniagua, F1
Fan, B; Ke, A; Le, K; Prakash, C; Yang, H1
Aman, AT; Ambara, A; Annisa, L; Darma, S; Nuryastuti, T; Wibawa, T1
Bhagat, J; Nakayama, H; Nishimura, N; Shimada, Y; Zang, L1
Araújo, RPC; Deegan, KR; Fonseca, MS; Machado, BAS; Meyer, R; Portela, RW; Sokolonski, AR; Umsza-Guez, MA1
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A1
Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ1
Buapeth, KO; Chaisut, M; Chanchayanon, B; Indoung, S; Jantrakajorn, S; Morteh, R1
Hull, B; Wedrychowicz, A1
Alavi, A; Khosravi, AR; Nikaein, D; Sharifzadeh, A; Shirani, D1
Hargrove, TY; Hill, GC; Kleshchenko, YY; Lepesheva, GI; Nes, WD; Ott, RD; Schuster, I; Villalta, F; Waterman, MR1
Driscoll, MD; Lafite, P; Levy, C; Leys, D; Mast, N; McLean, KJ; Munro, AW; Pikuleva, IA; Rigby, SE1
Emami, S; Keighobadi, M; Tavangar, P1
Bizzarri, B; Carradori, S; D'Ascenzio, M; De Monte, C; Grande, R; Mari, E; Patsilinakos, A; Ragno, R; Rivanera, D; Sabatino, M; Secci, D; Zicari, A1
Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z1
Cheng, M; Hao, C; Jiang, X; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S1
Wang, SQ; Wang, YF; Xu, Z1
Sun, B; Sun, N; Sun, Y; Tian, L; Zhao, D; Zhao, L; Zhao, S1
Braga, SS1
Gao, F; Huang, G; Xiao, J1
Jaisingh, A; Maurya, IK; Salunke, DB; Singh, R1
Billamboz, M; Dascalu, AE; Fayeulle, A; Furman, C; Ghinet, A; Lipka, E; Rigo, B1
Cheng, M; Su, X; Sun, N; Sun, Y; Tian, L; Yin, W; Zhang, C; Zhao, D; Zhao, L; Zhao, S; Zheng, Y1
Cheng, M; Cui, H; Jiang, H; Li, S; Liu, L; Su, X; Sun, Y; Wu, T; Yin, W; Zhang, Y; Zhao, D; Zhao, L; Zheng, Y1
Guengerich, FP; Hargrove, TY; Lepesheva, GI; Nes, WD; Rachakonda, G; Villalta, F; Wawrzak, Z1
Emami, S; Ghobadi, E; Saednia, S1
Han, J; Liu, M; Liu, W; Liu, Y; Sun, B; Wang, Q; Yu, S1

Reviews

102 review(s) available for fluconazole and ketoconazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Clinical significance of interactions with antifungal agents.
    The British journal of dermatology, 1992, Volume: 126 Suppl 39

    Topics: Antifungal Agents; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Humans; Itraconazole; Ketoconazole

1992
Azole antifungal agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14 Suppl 1

    Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses

1992
Histoplasmosis in Indianapolis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14 Suppl 1

    Topics: Amphotericin B; Disease Outbreaks; Fluconazole; Histoplasmosis; Humans; Indiana; Itraconazole; Ketoconazole

1992
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
    Presse medicale (Paris, France : 1983), 1992, May-30, Volume: 21, Issue:20

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections

1992
[Current developments in antimycotic therapy in gynecology and obstetrics].
    Der Gynakologe, 1992, Volume: 25, Issue:4

    Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious

1992
Antifungal treatment strategy in leukemia patients.
    Annals of hematology, 1992, Volume: 65, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed

1992
[Therapy of pulmonary mycoses].
    Deutsche medizinische Wochenschrift (1946), 1992, Nov-06, Volume: 117, Issue:45

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal

1992
Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs.
    Respiration; international review of thoracic diseases, 1992, Volume: 59, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Azoles; Clotrimazole; Disease Models, Animal; Fluconazole; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Otitis Externa

1992
[Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis].
    Minerva ginecologica, 1992, Volume: 44, Issue:12

    Topics: Adult; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle Aged

1992
Drug interactions: Part I.
    The Annals of pharmacotherapy, 1992, Volume: 26, Issue:5

    Topics: Antidepressive Agents, Tricyclic; Caffeine; Cimetidine; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Fluconazole; Fluoxetine; Hexobarbital; Humans; Ketoconazole; Nimodipine; Oxidoreductases; Pharmaceutical Preparations; Rifampin; Stereoisomerism; Warfarin; Zidovudine

1992
Drug interactions: part II.
    The Annals of pharmacotherapy, 1992, Volume: 26, Issue:6

    Topics: Amiodarone; Biological Availability; Dapsone; Didanosine; Drug Interactions; Fluconazole; Food; Humans; Intestinal Absorption; Ketoconazole; Pharmaceutical Preparations; Rifampin

1992
[Importance of the new triazoles in antifungal therapy].
    Mikrobiyoloji bulteni, 1991, Volume: 25, Issue:1

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses

1991
Diagnosis and treatment of oral candidosis.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1991, Volume: 49, Issue:9

    Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Opportunistic Infections

1991
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
    Lancet (London, England), 1991, Jun-29, Volume: 337, Issue:8757

    Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses

1991
Fungal infections and their management.
    British journal of clinical practice. Supplement, 1990, Volume: 71

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles

1990
Pharmacokinetics of oral antifungals and their clinical implications.
    British journal of clinical practice. Supplement, 1990, Volume: 71

    Topics: Absorption; Administration, Oral; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Tissue Distribution

1990
Fluconazole and itraconazole for vulvo-vaginal candidosis.
    Drug and therapeutics bulletin, 1990, Jan-22, Volume: 28, Issue:2

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole

1990
New antifungal agents for the systemic mycoses.
    Mycopathologia, 1990, Volume: 109, Issue:2

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Structure; Mycoses

1990
The triazole antifungal agents: a review of itraconazole and fluconazole.
    Pharmacotherapy, 1990, Volume: 10, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida albicans; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cryptococcus neoformans; Fluconazole; Half-Life; Humans; Itraconazole; Ketoconazole; Metabolic Clearance Rate

1990
Azoles and AIDS.
    The Journal of infectious diseases, 1990, Volume: 162, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Meningitis; Mycoses; Opportunistic Infections

1990
[Systemic mycotic infections].
    Recenti progressi in medicina, 1990, Volume: 81, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses

1990
Testing of organisms for susceptibility to triazoles: is it justified?
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5

    Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles

1989
New antifungal agents.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles

1989
Itraconazole and fluconazole: new drugs for deep fungal infection.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 24, Issue:3

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses

1989
Toxicological profile and safety evaluation of antifungal azole derivatives.
    Mycoses, 1989, Volume: 32 Suppl 1

    Topics: Abnormalities, Drug-Induced; Animals; Antifungal Agents; Endocrine Glands; Fluconazole; Humans; Itraconazole; Ketoconazole; Liver

1989
Azole antifungal agents: emphasis on new triazoles.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1

    Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles

1988
Recent advances in the treatment of systemic fungal infections.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1987
Azole antifungal drugs: old and new.
    Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3

    Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles

1988
Treatment of systemic fungal infections: recent progress and current problems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1988
New oral treatments for dermatophytosis.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles

1988
The systemic treatment of onychomycosis.
    Clinics in podiatric medicine and surgery, 1995, Volume: 12, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

1995
[Therapy of candidiasis and cryptococcosis in AIDS].
    Mycoses, 1994, Volume: 37 Suppl 2

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole

1994
Can we prevent azole resistance in fungi?
    Lancet (London, England), 1995, Aug-19, Volume: 346, Issue:8973

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole

1995
Antifungal chemotherapy.
    Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 1995, Volume: 44

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine

1995
Antifungal drugs.
    Pediatrics in review, 1995, Volume: 16, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses

1995
Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T-Lymphocytes; Clotrimazole; Fluconazole; HIV Infections; Humans; Ketoconazole; Leukocyte Count; Nystatin; Risk Factors

1994
Histoplasmosis: recognition and treatment.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19 Suppl 1

    Topics: Amphotericin B; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Serologic Tests

1994
Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.
    Clinical pharmacokinetics, 1994, Volume: 27, Issue:1

    Topics: Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Heart; Humans; Itraconazole; Ketoconazole; Prodrugs; Terfenadine

1994
Current therapy of dermatophytosis.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Time Factors; Tolnaftate

1994
Oral therapeutic agents in fungal nail disease.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome

1994
Antifungal therapy: potential interactions with other classes of drugs.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses

1994
Fungal peritonitis in patients on peritoneal dialysis.
    American journal of nephrology, 1994, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administration Routes; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Kidney Failure, Chronic; Length of Stay; Male; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Risk Factors; Treatment Outcome

1994
Itraconazole and fluconazole in oropharyngeal candidiasis.
    Annals of dentistry, 1993,Winter, Volume: 52, Issue:2

    Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Pharyngeal Diseases

1993
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:12

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; United States

1993
Ketoconazole and fluconazole drug interactions.
    Archives of internal medicine, 1993, Sep-13, Volume: 153, Issue:17

    Topics: Drug Interactions; Fluconazole; Humans; Ketoconazole

1993
Systemic drugs in the treatment of dermatophytoses.
    International journal of dermatology, 1993, Volume: 32, Issue:1

    Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Molecular Structure

1993
Onychomycosis. Agents of choice.
    Dermatologic clinics, 1993, Volume: 11, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

1993
[New antifungal agents in the treatment of superficial dermatomycoses].
    Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Azoles; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tolnaftate

1993
New antifungal drugs for pulmonary mycoses.
    Chest, 1996, Volume: 110, Issue:2

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal

1996
The role of azole antifungal agents for systemic antifungal therapy.
    Cleveland Clinic journal of medicine, 1997, Volume: 64, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Drug Costs; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole

1997
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
    BMJ (Clinical research ed.), 1997, Apr-26, Volume: 314, Issue:7089

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic

1997
Use of azoles for systemic antifungal therapy.
    Advances in pharmacology (San Diego, Calif.), 1997, Volume: 39

    Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1997
Azole resistance in Candida.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:4

    Topics: Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mucous Membrane

1997
Current trends in onychomycosis therapy: a literature review.
    The Mount Sinai journal of medicine, New York, 1997, Volume: 64, Issue:6

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

1997
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies

1995
[Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Multicenter Studies as Topic; Mycoses; Pancreas Transplantation; Risk Factors; Transplantation

1995
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Clinical Trials as Topic; Cryptococcosis; Drug Resistance, Microbial; Esophageal Diseases; Female; Fluconazole; Fungi; Humans; Ketoconazole; Male; Retrospective Studies

1995
[Superficial mycoses in immunosuppressed patients].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles

1995
[Antifungal agent resistance of yeasts of clinical significance].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Yeasts

1995
[Commonly used antifungal agents in the treatment of systemic mycoses].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis

1995
Onychomycosis: pathogenesis, diagnosis, and management.
    Clinical microbiology reviews, 1998, Volume: 11, Issue:3

    Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine

1998
Antifungal agents. Part II. The azoles.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Drug Interactions; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole

1999
Dermatophyte infections in children.
    Advances in pediatric infectious diseases, 1999, Volume: 14

    Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Naphthalenes; Terbinafine; Tinea; Trichophyton

1999
Treatment of recurrent vulvovaginal candidiasis.
    American family physician, 2000, Jun-01, Volume: 61, Issue:11

    Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles

2000
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
    International journal of dermatology, 2000, Volume: 39, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

2000
The treatment of dermatophytosis: safety considerations.
    Journal of the American Academy of Dermatology, 2000, Volume: 43, Issue:5 Suppl

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine

2000
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Dental update, 2000, Volume: 27, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence

2000
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2001, Volume: 92, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome

2001
A plea to bridge the gap between antifungals and the management of onychomycosis.
    American journal of clinical dermatology, 2001, Volume: 2, Issue:5

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

2001
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles

2000
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
    Journal of veterinary pharmacology and therapeutics, 2003, Volume: 26, Issue:1

    Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs

2003
Framing the future of antifungals in atopic dermatitis.
    Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:4

    Topics: Antifungal Agents; Dermatitis, Atopic; Fluconazole; Forecasting; Humans; Itraconazole; Ketoconazole; Treatment Outcome

2003
The use of oral antifungal agents to treat onychomycosis.
    Dermatologic clinics, 2003, Volume: 21, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

2003
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
    Orvosi hetilap, 2003, Aug-24, Volume: 144, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses

2003
Antifungal pharmacotherapy for neonatal candidiasis.
    Seminars in perinatology, 2003, Volume: 27, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
History of the development of azole derivatives.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10 Suppl 1

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole

2004
Candidiasis (vulvovaginal).
    Clinical evidence, 2003, Issue:9

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Sexual Partners

2003
Candidiasis (vulvovaginal).
    Clinical evidence, 2003, Issue:10

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Secondary Prevention; Sexual Partners

2003
Pharmacological management of paracoccidioidomycosis.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:3

    Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole

2005
Phaeohyphomycosis in Korea.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2005, Volume: 46, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Dermatomycoses; Exophiala; Female; Fluconazole; Humans; Hyphae; Itraconazole; Ketoconazole; Male; Middle Aged; Subcutaneous Tissue

2005
[Drug-drug interaction of antifungal drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:10

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Clinical status of agents being developed for leishmaniasis.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:11

    Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine

2005
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
    Clinical techniques in small animal practice, 2005, Volume: 20, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Severity of Illness Index

2005
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4

    Topics: Adult; Antifungal Agents; Critical Illness; Fluconazole; Humans; Immunocompromised Host; Incidence; Ketoconazole; Mycoses; Randomized Controlled Trials as Topic

2006
Fungal nail infections.
    Clinical evidence, 2005, Issue:14

    Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

2005
Candidiasis (vulvovaginal).
    Clinical evidence, 2005, Issue:14

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Nystatin; Secondary Prevention

2005
Fungal toenail infections.
    Clinical evidence, 2006, Issue:15

    Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine

2006
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:8

    Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine

2007
[Prophylactic antifungal treatment in critically ill patients. A survey of a Cochrane review].
    Ugeskrift for laeger, 2008, Jan-07, Volume: 170, Issue:1

    Topics: Adult; Antifungal Agents; Critical Illness; Evidence-Based Medicine; Fluconazole; Humans; Immunocompromised Host; Ketoconazole; Mycoses

2008
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
    Rheumatology international, 2009, Volume: 29, Issue:10

    Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome

2009
Conazoles.
    Molecules (Basel, Switzerland), 2010, Jun-09, Volume: 15, Issue:6

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole

2010
Systemic antifungal therapy for tinea capitis in children.
    The Cochrane database of systematic reviews, 2016, May-12, Issue:5

    Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis

2016
Tinea capitis in children: a systematic review of management.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:12

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Specimen Handling; Terbinafine; Tinea Capitis; Trichophyton

2018
Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:10

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Clotrimazole; Drug Therapy, Combination; Evidence-Based Medicine; Fluconazole; Humans; Ketoconazole; Miconazole; Nystatin

2019
The function of adrenal glands in children and adolescents during and after oncological treatment.
    Pediatric endocrinology, diabetes, and metabolism, 2022, Volume: 28, Issue:3

    Topics: Adolescent; Adrenal Glands; Child; Etomidate; Fluconazole; Humans; Hypothalamo-Hypophyseal System; Immune Checkpoint Inhibitors; Ketoconazole; Metyrapone; Mitotane; Pituitary-Adrenal System; Quality of Life

2022
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
    European journal of medicinal chemistry, 2017, Jul-28, Volume: 135

    Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase

2017
Tetrazole hybrids and their antifungal activities.
    European journal of medicinal chemistry, 2019, May-15, Volume: 170

    Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles

2019
Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research.
    Bioorganic & medicinal chemistry letters, 2019, 08-15, Volume: 29, Issue:16

    Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Development; Heme; Humans; Hydrophobic and Hydrophilic Interactions; Protein Binding

2019
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole

2019
Current scenario of tetrazole hybrids for antibacterial activity.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles

2019
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development.
    European journal of medicinal chemistry, 2022, Mar-05, Volume: 231

    Topics: Antifungal Agents; Drug Development; Fungi; Voriconazole

2022

Trials

36 trial(s) available for fluconazole and ketoconazole

ArticleYear
Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
    Annals of internal medicine, 1992, Oct-15, Volume: 117, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Double-Blind Method; Esophagitis; Esophagoscopy; Female; Fluconazole; Humans; Ketoconazole; Male

1992
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Chemotherapy, 1992, Volume: 38 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections; Oropharynx; Pilot Projects

1992
[Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis].
    Minerva ginecologica, 1992, Volume: 44, Issue:12

    Topics: Adult; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle Aged

1992
Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man.
    British journal of clinical pharmacology, 1992, Volume: 34, Issue:1

    Topics: Administration, Oral; Adult; Fluconazole; Humans; Ketoconazole; Male; Phenytoin; Random Allocation; Testosterone

1992
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule; Fluconazole; HIV Infections; Humans; Ketoconazole; Recurrence

1991
Increased gastric pH and the bioavailability of fluconazole and ketoconazole.
    Annals of internal medicine, 1991, May-01, Volume: 114, Issue:9

    Topics: Adult; Biological Availability; Cimetidine; Drug Interactions; Fluconazole; Gastric Acidity Determination; Humans; Ketoconazole; Male; Random Allocation; Statistics as Topic

1991
The triazole antifungal agents: a review of itraconazole and fluconazole.
    Pharmacotherapy, 1990, Volume: 10, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida albicans; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cryptococcus neoformans; Fluconazole; Half-Life; Humans; Itraconazole; Ketoconazole; Metabolic Clearance Rate

1990
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
    Lancet (London, England), 1989, Apr-08, Volume: 1, Issue:8641

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Prospective Studies; Recurrence; Triazoles

1989
Fluconazole and testosterone: in vivo and in vitro studies.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5

    Topics: Adult; Analysis of Variance; Animals; Antifungal Agents; Cells, Cultured; Double-Blind Method; Fluconazole; Humans; Ketoconazole; Leydig Cells; Male; Rats; Testosterone; Triazoles

1988
Single-dose oral fluconazole in the treatment of vaginal candidosis.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Fluconazole; Humans; Ketoconazole; Triazoles

1988
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
    European journal of obstetrics, gynecology, and reproductive biology, 1988, Volume: 29, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Multicenter Studies as Topic; Random Allocation; Recurrence; Triazoles

1988
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:1

    Topics: Administration, Oral; Adult; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Cross-Over Studies; Esophageal Diseases; Female; Fluconazole; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Oropharynx; Pharyngeal Diseases; Saliva

1995
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:1

    Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth

1995
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
    International journal of dermatology, 1994, Volume: 33, Issue:10

    Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Placebos; Recurrence; Remission Induction; Superinfection; Tinea; Tinea Pedis; Trichophyton

1994
Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:4

    Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Child; Child, Preschool; Female; Fluconazole; Humans; Immunocompromised Host; Infant; Infant, Newborn; Ketoconazole; Male; Pharyngeal Diseases; Prospective Studies; Time Factors

1994
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Prospective Studies; Recurrence; Time Factors

1994
Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.
    Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:3

    Topics: Adult; Antifungal Agents; Cimetidine; Fluconazole; Histamine H2 Antagonists; Humans; Ketoconazole; Male; Microsomes, Liver; Reference Values; Sulfamethoxazole

1996
The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:3

    Topics: Adult; Anti-Infective Agents; Antifungal Agents; Fluconazole; Humans; Hydroxylation; Ketoconazole; Male; Middle Aged; Sulfamethoxazole

1996
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Reference Values; Risk Factors

1996
Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Predictive Value of Tests

1997
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
    Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:6

    Topics: Administration, Oral; Adult; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Female; Fluconazole; Half-Life; Humans; Hypnotics and Sedatives; Itraconazole; Ketoconazole; Male; Pyridines; Reference Values; Zolpidem

1998
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
    Zhonghua nei ke za zhi, 1997, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconazole; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Vaginitis

1997
Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study.
    The Journal of dermatology, 2001, Volume: 28, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Child; Drug Administration Schedule; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Tinea Versicolor; Treatment Outcome

2001
Fluconazole versus ketoconazole in the treatment of tinea versicolor.
    The Journal of dermatological treatment, 2002, Volume: 13, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Exanthema; Fatigue; Female; Fluconazole; Follow-Up Studies; Headache; Humans; Ketoconazole; Malassezia; Male; Middle Aged; Safety; Tinea Versicolor; Treatment Outcome

2002
Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis.
    Japanese journal of infectious diseases, 2004, Volume: 57, Issue:6

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Humans; Ketoconazole; Male; Middle Aged; Onychomycosis

2004
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide.
    British journal of clinical pharmacology, 2005, Volume: 60, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Female; Fluconazole; Humans; Ketoconazole; Male; Pentanoic Acids; Receptors, Cholecystokinin; Time Factors

2005
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene.
    British journal of clinical pharmacology, 2007, Volume: 63, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antifungal Agents; Area Under Curve; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Paroxetine; Postmenopause; Pyrrolidines; Tetrahydronaphthalenes

2007
Antifungal treatment in sarcoidosis--a pilot intervention trial.
    Respiratory medicine, 2007, Volume: 101, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Pilot Projects; Sarcoidosis; Treatment Outcome

2007
Value of colposcopy in the diagnosis of candidiasis in patients with vulvodynia.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Colposcopy; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Pain; Vulvar Diseases

2007
Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Mycoses, 2007, Volume: 50, Issue:4

    Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Iran; Ketoconazole; Male; Surveys and Questionnaires; Tinea Versicolor

2007
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.
    Mymensingh medical journal : MMJ, 2009, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Bangladesh; Female; Fluconazole; Humans; Incidence; Itraconazole; Ketoconazole; Male; Middle Aged; Prevalence; Risk Factors; Tinea Versicolor; Treatment Outcome; Young Adult

2009
Quantitative prediction and clinical observation of a CYP3A inhibitor-based drug-drug interactions with MLN3897, a potent C-C chemokine receptor-1 antagonist.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:2

    Topics: Adult; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Hepatocytes; Humans; Ketoconazole; Male; Microsomes, Liver; Models, Biological; Receptors, CCR1

2010
A noninferiority clinical trial comparing fluconazole and ketoconazole in combination with cephalexin for the treatment of dogs with Malassezia dermatitis.
    Veterinary therapeutics : research in applied veterinary medicine, 2010,Summer, Volume: 11, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cephalexin; Dermatomycoses; Dog Diseases; Dogs; Drug Therapy, Combination; Fluconazole; Ketoconazole; Malassezia

2010
Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant.
    Clinical drug investigation, 2013, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Antidepressive Agents; Antifungal Agents; Bupropion; Cohort Studies; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Fluconazole; Humans; Ketoconazole; Male; Middle Aged; Omeprazole; Piperazines; Rifampin; Single-Blind Method; Sulfides; Vortioxetine; Young Adult

2013
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor.
    La Tunisie medicale, 2016, Volume: 94, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Hair Preparations; Humans; Ketoconazole; Male; Middle Aged; Tinea Versicolor; Young Adult

2016
Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Benzothiazoles; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluconazole; fms-Like Tyrosine Kinase 3; Healthy Volunteers; Humans; Invasive Fungal Infections; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Phenylurea Compounds; Young Adult

2019

Other Studies

434 other study(ies) available for fluconazole and ketoconazole

ArticleYear
Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring.
    Journal of medicinal chemistry, 1995, Sep-29, Volume: 38, Issue:20

    Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Female; Male; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship

1995
Novel antifungals based on 4-substituted imidazole: a combinatorial chemistry approach to lead discovery and optimization.
    Bioorganic & medicinal chemistry letters, 2000, Oct-02, Volume: 10, Issue:19

    Topics: Antifungal Agents; Candida; Combinatorial Chemistry Techniques; Drug Design; Ergosterol; Fungi; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2000
3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugs.
    Journal of medicinal chemistry, 2001, Aug-16, Volume: 44, Issue:17

    Topics: 4-Butyrolactone; Amphotericin B; Antifungal Agents; Fungi; Furans; Humans; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship

2001
Interaction of common azole antifungals with P glycoprotein.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Cell Line; Hydrolysis; Mice

2002
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
    Molecular pharmacology, 2002, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine

2002
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine

2002
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
    Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21

    Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship

2003
Imidazole analogues of fluoxetine, a novel class of anti-Candida agents.
    Journal of medicinal chemistry, 2004, Jul-29, Volume: 47, Issue:16

    Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Fluoxetine; Humans; Imidazoles; Microbial Sensitivity Tests; Structure-Activity Relationship

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
    Journal of medicinal chemistry, 2006, Apr-20, Volume: 49, Issue:8

    Topics: Antifungal Agents; Azoles; Binding Sites; Databases, Factual; Fungi; Hydrogen Bonding; In Vitro Techniques; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship

2006
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols

2007
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:3

    Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase

2007
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole

2007
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
    European journal of medicinal chemistry, 2007, Volume: 42, Issue:9

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles

2007
Discovery of novel indazole-linked triazoles as antifungal agents.
    Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillus; Candida; Disease Models, Animal; Indazoles; Mice; Microbial Sensitivity Tests; Rats; Stereoisomerism; Triazoles

2007
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Role for cell density in antifungal drug resistance in Candida albicans biofilms.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests

2007
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Germany; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Oropharynx; Vitis

2007
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole

2007
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
    Journal of medicinal chemistry, 2007, Nov-01, Volume: 50, Issue:22

    Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases

2007
Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51).
    Bioorganic & medicinal chemistry, 2008, Jan-01, Volume: 16, Issue:1

    Topics: Anticholesteremic Agents; Binding Sites; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholesterol; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Oxidoreductases; Pyridines; Sterol 14-Demethylase; Structure-Activity Relationship

2008
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
    Bioorganic & medicinal chemistry, 2008, Jan-15, Volume: 16, Issue:2

    Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States

2008
In vitro antifungal susceptibilities of five species of sporothrix.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis

2008
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts

2008
Potent in vitro antifungal activities of naturally occurring acetylenic acids.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Alkynes; Animals; Antifungal Agents; Candida albicans; Cell Line; Fatty Acids, Unsaturated; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Rubiaceae; Trichophyton

2008
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
    Bioorganic & medicinal chemistry letters, 2008, Jun-01, Volume: 18, Issue:11

    Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts

2008
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    Journal of medicinal chemistry, 2008, Jul-10, Volume: 51, Issue:13

    Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Cell Line, Tumor; Cell Survival; Computer Simulation; Humans; Imidazoles; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship

2008
Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Antifungal Agents; Azoles; Base Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Genes, Fungal; Humans; Molecular Sequence Data; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Sterol 14-Demethylase

2008
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes

2008
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae

2009
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Amino Acid Motifs; Amino Acid Sequence; Azoles; Base Sequence; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genes, Bacterial; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Structure; Molecular Weight; Mycobacterium leprae; Mycobacterium smegmatis; Osmolar Concentration; Recombinant Proteins; Sequence Homology, Amino Acid; Sodium Chloride

2009
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:5

    Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles

2009
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
    Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3

    Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Triazoles

2009
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:7

    Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results

2009
In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Antifungal Agents; Azoles; Candida albicans; Fluconazole; Itraconazole; Ketoconazole; Lichens; Microbial Sensitivity Tests; Triterpenes

2009
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Fungal; Europe; Female; Fluconazole; Genotype; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence

2009
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines

2009
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
    Bioorganic & medicinal chemistry letters, 2009, Mar-15, Volume: 19, Issue:6

    Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles

2009
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Adult; Aerobiosis; Antifungal Agents; Azoles; Candida glabrata; Chromatography, High Pressure Liquid; Ergosterol; Female; Flow Cytometry; Genes, Fungal; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Polyenes

2009
Bulky 1,4-benzoxazine derivatives with antifungal activity.
    Bioorganic & medicinal chemistry, 2009, Jun-01, Volume: 17, Issue:11

    Topics: Animals; Antifungal Agents; Benzoxazines; Candida; Cryptococcus neoformans; Female; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure

2009
In vitro activity of thimerosal against ocular pathogenic fungi.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Animals; Anti-Infective Agents; Cell Line; Ecology; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Oxazines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship

2010
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:9

    Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells

2010
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:10

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles

2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole

2010
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity

2011
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:7

    Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
    European journal of medicinal chemistry, 2012, Volume: 47, Issue:1

    Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface

2012
Synthesis of novel spirooxindole derivatives by one pot multicomponent reaction and their antimicrobial activity.
    European journal of medicinal chemistry, 2012, Volume: 51

    Topics: Anti-Infective Agents; Bacteria; Chemistry Techniques, Synthetic; Fungi; Indoles; Microbial Sensitivity Tests; Oxindoles

2012
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
    Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8

    Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles

2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Synthesis, in vitro antifungal activity and in silico study of 3-(1,2,4-triazol-1-yl)flavanones.
    European journal of medicinal chemistry, 2013, Volume: 66

    Topics: Antifungal Agents; Catalytic Domain; Chemistry Techniques, Synthetic; Flavanones; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Sterol 14-Demethylase

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synthesis and evaluation of novel azoles as potent antifungal agents.
    Bioorganic & medicinal chemistry letters, 2014, Jan-01, Volume: 24, Issue:1

    Topics: Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2014
Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates.
    European journal of medicinal chemistry, 2014, Mar-03, Volume: 74

    Topics: Aspergillus fumigatus; Candida; Carbamates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation

2014
Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka.
    Journal of natural products, 2014, May-23, Volume: 77, Issue:5

    Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Cyclohexanols; Holothuria; Humans; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Trichophyton

2014
Thiophene and benzodioxole appended thiazolyl-pyrazoline compounds: Microwave assisted synthesis, antimicrobial and molecular docking studies.
    Bioorganic & medicinal chemistry letters, 2015, Jul-15, Volume: 25, Issue:14

    Topics: Anti-Infective Agents; Benzodioxoles; Binding Sites; DNA Topoisomerase IV; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Microwaves; Molecular Docking Simulation; Protein Binding; Pyrazoles; Structure-Activity Relationship; Thermodynamics; Thiazoles; Thiophenes

2015
Phenoxymethyl 1,3-oxazoles and 1,2,4-oxadiazoles as potent and selective agonists of free fatty acid receptor 1 (GPR40).
    Bioorganic & medicinal chemistry letters, 2015, Aug-15, Volume: 25, Issue:16

    Topics: Animals; Binding Sites; Caco-2 Cells; Cytochrome P-450 Enzyme System; Half-Life; Humans; Methylamines; Mice; Molecular Docking Simulation; Oxadiazoles; Oxazoles; Propionates; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Structure-Activity Relationship

2015
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
    Bioorganic & medicinal chemistry, 2015, Sep-01, Volume: 23, Issue:17

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans

2015
Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: 14-alpha Demethylase Inhibitors; Anti-Bacterial Agents; Antifungal Agents; Candida; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Fungal Proteins; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Small Molecule Libraries; Sterol 14-Demethylase; Structure-Activity Relationship; Thiazolidines

2016
Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzofurans; Biological Availability; Drug Discovery; Enzyme Inhibitors; Female; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Oxidoreductases; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Tissue Distribution

2016
Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties.
    European journal of medicinal chemistry, 2016, Jul-19, Volume: 117

    Topics: Antifungal Agents; Antioxidants; Candida; Chelating Agents; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Thiazolidines; Toxicity Tests

2016
Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN).
    Journal of medicinal chemistry, 2016, 05-26, Volume: 59, Issue:10

    Topics: Alkanes; Anti-Bacterial Agents; Antifungal Agents; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Fungi; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Oxidoreductases; Staphylococcal Infections; Structure-Activity Relationship

2016
2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists.
    Journal of medicinal chemistry, 2016, 05-26, Volume: 59, Issue:10

    Topics: Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hep G2 Cells; Hepatocytes; Humans; Models, Molecular; Molecular Structure; Quinazolines; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship

2016
Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold.
    Bioorganic & medicinal chemistry, 2016, 07-01, Volume: 24, Issue:13

    Topics: Amides; Animals; Drug Delivery Systems; Humans; Hypoglycemic Agents; Mice; Microsomes, Liver; Molecular Docking Simulation; Protein Binding; Receptors, G-Protein-Coupled; Thiadiazoles

2016
Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies.
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Antifungal Agents; Biphenyl Compounds; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Discovery; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2017
Design, synthesis, and in vitro evaluation of novel antifungal triazoles.
    Bioorganic & medicinal chemistry letters, 2017, 05-15, Volume: 27, Issue:10

    Topics: Antifungal Agents; Crystallography, X-Ray; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Conformation; Nitriles; Pyridines; Structure-Activity Relationship; Thiazoles; Triazoles

2017
Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents.
    European journal of medicinal chemistry, 2017, Sep-08, Volume: 137

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Heterocyclic Compounds; Hydrocarbons, Aromatic; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2017
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
    Journal of medicinal chemistry, 2017, 10-12, Volume: 60, Issue:19

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Bacterial; Ether-A-Go-Go Potassium Channels; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship; Vancomycin; Vancomycin Resistance; Xanthophylls

2017
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
    Journal of medicinal chemistry, 2018, 01-11, Volume: 61, Issue:1

    Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water

2018
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship

2019
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:6

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Diseases; Female; Fluconazole; Humans; Ketoconazole; Male; Middle Aged

1992
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1992, Feb-21, Volume: 34, Issue:864

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections

1992
The evaluation of therapeutic responses in experimental keratomycosis.
    Current eye research, 1992, Volume: 11, Issue:1

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Fungal; Fluconazole; Itraconazole; Keratitis; Ketoconazole; Observer Variation; Rabbits

1992
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:1

    Topics: Adult; Aged; Antifungal Agents; Azoles; Carbamazepine; Coccidioides; Cryptococcus neoformans; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Male; Middle Aged; Mycoses; Phenytoin; Rifampin

1992
[New treatments of onychomycoses].
    Annales de dermatologie et de venereologie, 1992, Volume: 119, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones

1992
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Chemotherapy, 1992, Volume: 38 Suppl 1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis

1992
[Sphenoid sinus aspergillosis presenting abducens nerve palsy and visual field impairment; a case report].
    No shinkei geka. Neurological surgery, 1992, Volume: 20, Issue:7

    Topics: Abducens Nerve; Aged; Antifungal Agents; Aspergillosis; Cranial Nerve Diseases; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Paralysis; Paranasal Sinus Diseases; Sphenoid Sinus; Visual Fields

1992
Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole.
    Chemotherapy, 1992, Volume: 38, Issue:3

    Topics: Alternaria; Antifungal Agents; Aspergillus; Candida; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Pseudallescheria

1992
New antifungal agents.
    Dermatologic clinics, 1992, Volume: 10, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine

1992
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
    European journal of epidemiology, 1992, Volume: 8, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles

1992
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Chemotherapy, 1992, Volume: 38, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity

1992
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
    International journal of immunopharmacology, 1992, Volume: 14, Issue:5

    Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus

1992
Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug-metabolism in mice and humans in vivo. Comparative study with ketoconazole.
    Chemical & pharmaceutical bulletin, 1992, Volume: 40, Issue:5

    Topics: Adult; Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Fluconazole; Humans; Hydrocortisone; Ketoconazole; Male; Mice; Microsomes, Liver; Middle Aged

1992
Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.
    Journal of general microbiology, 1992, Volume: 138, Issue:9

    Topics: Candida albicans; Candidiasis, Oral; DNA, Fungal; Fluconazole; HIV Infections; Humans; Ketoconazole; Lipids; Microbial Sensitivity Tests; Sterols

1992
Cryptococcal peritonitis in a CAPD patient.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1992, Volume: 30, Issue:4

    Topics: Cryptococcosis; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis

1992
[Q-DIPS: current approach to prediction of drug interactions].
    Schweizerische medizinische Wochenschrift, 1992, Dec-12, Volume: 122, Issue:50

    Topics: Biotransformation; Computer Simulation; Drug Interactions; Fluconazole; Humans; Ketoconazole; Liver; Pharmacokinetics; Probability; Software

1992
Cryptococcal meningitis in AIDS occurring despite systemic antifungal therapy.
    The Journal of infection, 1992, Volume: 24, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Ketoconazole; Meningitis, Cryptococcal

1992
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:1

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Injections, Intravenous; Ketoconazole; Kidney; Male; Mice; Triazoles

1992
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells.
    International journal of immunopharmacology, 1991, Volume: 13, Issue:2-3

    Topics: Antifungal Agents; Cytokines; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Itraconazole; Ketoconazole; Lymphocyte Activation; Miconazole; T-Lymphocytes

1991
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:3

    Topics: Antifungal Agents; Candida; Cryptococcus; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1991
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
    British journal of clinical pharmacology, 1991, Volume: 32, Issue:5

    Topics: Adult; Antifungal Agents; Cyclosporine; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Naphthalenes; Terbinafine

1991
The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitro.
    International journal of immunopharmacology, 1991, Volume: 13, Issue:7

    Topics: Antifungal Agents; Fluconazole; Humans; Immunity; Immunity, Innate; Immunosuppressive Agents; In Vitro Techniques; Itraconazole; Ketoconazole; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Culture Test, Mixed

1991
Candida zeylanoides: another opportunistic yeast.
    Journal of clinical microbiology, 1991, Volume: 29, Issue:8

    Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length

1991
Synergistic action of nikkomycin X/Z with azole antifungals on Candida albicans.
    Journal of general microbiology, 1991, Volume: 137, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Biological Transport; Candida albicans; Drug Synergism; Fluconazole; Glucose; Imidazoles; Ketoconazole; Kinetics; Polysaccharides

1991
Fluconazole resistance in AIDS patients.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Ketoconazole; Male; Microbial Sensitivity Tests

1991
[In vivo and in vitro antifungal activity of fluconazole].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:5

    Topics: Animals; Aspergillus; Candida albicans; Candidiasis; Cryptococcus; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Male; Mice; Mice, Inbred ICR; Miconazole

1991
Black grain eumycetoma (Madurella mycetomatis) in the abdominal cavity of a dog.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1991, Volume: 29, Issue:3

    Topics: Abdomen; Animals; Culture Media; Dog Diseases; Dogs; Escherichia coli; Female; Fluconazole; Granuloma; Ketoconazole; Mitosporic Fungi; Mycetoma

1991
Failure of ketoconazole maintenance therapy for disseminated coccidioidomycosis in AIDS.
    The Journal of infectious diseases, 1991, Volume: 164, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Coccidioidomycosis; Fluconazole; Humans; Ketoconazole; Male

1991
Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report.
    Mycopathologia, 1991, Volume: 115, Issue:1

    Topics: Aged; Agricultural Workers' Diseases; Brazil; Edema; Face; Female; Fluconazole; Fungi; Humans; Ketoconazole; Mycoses; Nose; Recurrence

1991
Bioavailability of fluconazole and ketoconazole in human stratum corneum and oral mucosa.
    Clinical and experimental dermatology, 1991, Volume: 16, Issue:3

    Topics: Adult; Biological Availability; Candida albicans; Fluconazole; Humans; Ketoconazole; Mouth Mucosa; Skin; Trichophyton

1991
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
    The American journal of gastroenterology, 1991, Volume: 86, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Esophagitis; Female; Fluconazole; Ganciclovir; Humans; Infusions, Intravenous; Ketoconazole; Male; Opportunistic Infections; Prospective Studies; Treatment Outcome

1991
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged

1990
Treatment of refractory oral candidiasis with fluconazole. A case report.
    Oral surgery, oral medicine, and oral pathology, 1991, Volume: 71, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clotrimazole; Deglutition Disorders; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Ketoconazole; Male

1991
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Chemotherapy, 1991, Volume: 37, Issue:1

    Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts

1991
Fluconazole resistant candida in AIDS.
    The Journal of infection, 1991, Volume: 22, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Ketoconazole; Male

1991
Candida albicans resistance in AIDS.
    The Journal of infection, 1991, Volume: 22, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Ketoconazole; Male

1991
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
    Journal of clinical periodontology, 1991, Volume: 18, Issue:5

    Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin

1991
SCH 39304 in the treatment of acute or established murine pulmonary blastomycosis.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4

    Topics: Animals; Antifungal Agents; Blastomycosis; Fluconazole; Ketoconazole; Lung Diseases; Mice; Mice, Inbred BALB C; Triazoles

1991
Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:10

    Topics: Candida; Fluconazole; Ketoconazole; Microbial Sensitivity Tests

1990
Diabetic ketoacidosis precipitated by primary genital herpes.
    International journal of STD & AIDS, 1990, Volume: 1, Issue:5

    Topics: Acyclovir; Adolescent; Adult; Diabetic Ketoacidosis; Female; Fluconazole; Herpes Simplex; Humans; Ketoconazole

1990
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:3

    Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles

1990
Treatment of murine coccidioidal meningitis with SCH39304.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:4

    Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Mice; Mice, Inbred BALB C; Triazoles

1990
Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cells, Cultured; Colony Count, Microbial; Fluconazole; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis

1990
[Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
    Pathologie-biologie, 1990, Volume: 38, Issue:5 ( Pt 2)

    Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts

1990
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:3

    Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Rabbits; Triazoles

1990
Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1990, Volume: 28, Issue:4

    Topics: Antifungal Agents; Aspergillus fumigatus; Binding, Competitive; Carbon Monoxide; Cytochrome P-450 Enzyme System; Fluconazole; Itraconazole; Ketoconazole; Microsomes; Spectrophotometry

1990
A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1990, Volume: 28, Issue:4

    Topics: Antifungal Agents; Aspergillus fumigatus; Autoradiography; Azoles; Chromatography, Thin Layer; Ergosterol; Fluconazole; Gas Chromatography-Mass Spectrometry; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Molecular Structure

1990
Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole.
    International journal of immunopharmacology, 1990, Volume: 12, Issue:6

    Topics: Antifungal Agents; Cells, Cultured; Chemotaxis, Leukocyte; Deoxyglucose; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Ketoconazole; Lymphocyte Activation; Neutrophils

1990
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1990, Jun-15, Volume: 32, Issue:820

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses

1990
Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:3

    Topics: Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; HIV Infections; HIV-1; Humans; Ketoconazole; Male; Middle Aged; Retrospective Studies

1990
[Comparison of fluconazole and ketoconazole in the therapy of vaginal candidiasis by administration in two different oral doses].
    Minerva ginecologica, 1990, Volume: 42, Issue:5

    Topics: Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole

1990
[Trichosporon capitatum septicemia in immunosuppressed patients].
    Pathologie-biologie, 1990, Volume: 38, Issue:5 ( Pt 2)

    Topics: Adult; Female; Fluconazole; Humans; Immune Tolerance; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Sepsis; Trichosporon

1990
[In vitro activity of fluconazole, a novel bistriazole antifungal agent].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Animals; Antifungal Agents; Ascitic Fluid; Aspergillus; Candida albicans; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Humans; Hydrogen-Ion Concentration; Ketoconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles; Yeasts

1989
[Recent antifungal agents].
    Pathologie-biologie, 1989, Volume: 37, Issue:2

    Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles

1989
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2

    Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles

1989
A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1989, Volume: 27, Issue:2

    Topics: Animals; Antifungal Agents; Candidiasis, Oral; Epithelium; Fluconazole; Image Processing, Computer-Assisted; Ketoconazole; Male; Microcomputers; Palate; Rats; Rats, Inbred Strains; Triazoles

1989
A comparative study of the effects of ketoconazole and fluconazole on 17-beta estradiol production by rat ovaries in vitro.
    Research communications in chemical pathology and pharmacology, 1989, Volume: 64, Issue:1

    Topics: Animals; Antifungal Agents; Estradiol; Female; Fluconazole; In Vitro Techniques; Ketoconazole; Ovary; Radioimmunoassay; Rats; Rats, Inbred Strains; Triazoles

1989
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
    Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles

1989
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
    Chemotherapy, 1989, Volume: 35, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles

1989
[Treatment of mycoses and new antifungal agents].
    La Revue du praticien, 1989, Sep-01, Volume: 39, Issue:19

    Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine

1989
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Annales de biologie clinique, 1989, Volume: 47, Issue:9

    Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts

1989
Genetic and physiological analysis of azole sensitivity in Saccharomyces cerevisiae.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1989, Volume: 27, Issue:6

    Topics: Cytochrome P-450 Enzyme System; Fluconazole; Ketoconazole; Mutation; Saccharomyces cerevisiae

1989
5-Lipoxygenase inhibition by antifungal azole derivatives: new tools for immunosuppression?
    Eicosanoids, 1989, Volume: 2, Issue:3

    Topics: Antifungal Agents; Arachidonate Lipoxygenases; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Itraconazole; Ketoconazole; Lipoxygenase Inhibitors; Neutrophils

1989
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
    Lancet (London, England), 1989, May-20, Volume: 1, Issue:8647

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Male; Pharyngeal Diseases; Triazoles

1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles

1987
Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity.
    Biochemical pharmacology, 1988, Feb-01, Volume: 37, Issue:3

    Topics: Animals; Antifungal Agents; Fluconazole; Ketoconazole; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred Strains; Substrate Specificity; Testosterone; Triazoles

1988
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:2

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Rabbits; Triazoles

1988
In vitro effects of fluconazole (UK-49,858) and ketoconazole on mouse lymphocyte proliferation and on Candida blastospore destruction by human polymorphonuclear leukocytes.
    International journal of immunopharmacology, 1988, Volume: 10, Issue:2

    Topics: Animals; Antifungal Agents; Candida albicans; Cytotoxicity, Immunologic; Fluconazole; Humans; In Vitro Techniques; Ketoconazole; Lymphocyte Activation; Mice; Mice, Inbred Strains; Neutrophils; Spores, Fungal; Triazoles

1988
Primary cutaneous phaeohyphomycosis. Report of three cases.
    Journal of the American Academy of Dermatology, 1988, Volume: 18, Issue:5 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Dermatomycoses; Female; Fluconazole; Humans; Immune Tolerance; Ketoconazole; Male; Triazoles

1988
[New antiparasitic drugs].
    Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:4

    Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles

1988
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
    Clinical pharmacy, 1988, Volume: 7, Issue:8

    Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Fluconazole; Humans; Intestinal Absorption; Ketoconazole; Triazoles

1988
Improved method for azole antifungal susceptibility testing.
    Journal of clinical microbiology, 1988, Volume: 26, Issue:9

    Topics: Antifungal Agents; Azoles; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles

1988
Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
    Molecular and biochemical parasitology, 1988, Volume: 31, Issue:2

    Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Cholesterol; Chromatography, Gas; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Leishmania; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Sterols; Triazoles

1988
Effects of two oral antimycotics, ketoconazole and fluconazole, upon steroidogenesis in rat adrenal cells in vitro.
    Journal of steroid biochemistry, 1988, Volume: 31, Issue:5

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antifungal Agents; Cells, Cultured; Dose-Response Relationship, Drug; Fluconazole; Ketoconazole; Male; Pregnenolone; Rats; Rats, Inbred Strains; Steroids; Triazoles

1988
Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:4

    Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Clotrimazole; Female; Fluconazole; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Neutrophils; Phagocytosis; Triazoles; Vagina

1988
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure-Activity Relationship; Tinea Versicolor; Triazoles

1988
The new generation of antifungal drugs.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:6

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles

1988
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
    Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles

1985
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:1

    Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Meningitis, Haemophilus; Rabbits; Triazoles

1985
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Intestinal Diseases; Ketoconazole; Kinetics; Mice; Triazoles

1985
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:4

    Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles

1986
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred ICR; Triazoles

1986
Azole resistance in Candida albicans.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:2

    Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles

1986
Treatment of cryptococcal meningitis in mice with fluconazole.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Meningitis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Rats; Rats, Inbred Strains; Triazoles

1986
Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
    The American review of respiratory disease, 1986, Volume: 134, Issue:4

    Topics: Animals; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Ketoconazole; Lung Diseases, Fungal; Male; Mice; Mice, Inbred ICR; Mice, Nude; Triazoles

1986
Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:3

    Topics: Animals; Antifungal Agents; Buffers; Candida albicans; Culture Media; Fluconazole; Fungal Proteins; Hydrogen-Ion Concentration; Ketoconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Triazoles

1986
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles

1987
Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:2

    Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Ketoconazole; Miconazole; Triazoles

1987
Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
    Mykosen, 1987, Volume: 30, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Culture Techniques; Fluconazole; Histoplasma; Histoplasmosis; Ketoconazole; Male; Mice; Triazoles

1987
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles

1987
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:1

    Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles

1987
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995
Effect of azoles on the glucuronidation of zidovudine by human liver UDP-glucuronosyltransferase.
    The Journal of infectious diseases, 1995, Volume: 172, Issue:6

    Topics: Antifungal Agents; Antiviral Agents; Drug Interactions; Fluconazole; Glucuronosyltransferase; Humans; Itraconazole; Ketoconazole; Liver; Zidovudine

1995
Resistance to azole drugs in Neurospora crassa.
    Experimental mycology, 1995, Volume: 19, Issue:2

    Topics: Antifungal Agents; Crosses, Genetic; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Meiosis; Mutagenesis; Neurospora crassa; Selection, Genetic; Triazoles

1995
Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients.
    FEBS letters, 1995, Jul-17, Volume: 368, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Tolerance; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsomes; Oxidoreductases; Sterol 14-Demethylase; Sterols; Treatment Failure

1995
[Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
    Mycoses, 1995, Volume: 38 Suppl 1

    Topics: Amphotericin B; Candida albicans; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Lipids; Miconazole; Microbial Sensitivity Tests; Structure-Activity Relationship

1995
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
    Journal of industrial microbiology, 1995, Volume: 14, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Silicones; Urinary Catheterization

1995
Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors.
    Pharmacogenetics, 1995, Volume: 5, Issue:2

    Topics: Adrenal Glands; Animals; Base Sequence; Cell Line; Cloning, Molecular; Clotrimazole; Cricetinae; Cricetulus; DNA Primers; DNA, Complementary; Fluconazole; Gene Expression; Hydrocortisone; Hydroxylation; Ketoconazole; Kinetics; Metyrapone; Miconazole; Mitochondria; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Restriction Mapping; Spironolactone; Steroid 11-beta-Hydroxylase; Transfection

1995
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:3

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Double-Blind Method; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prospective Studies; Sensitivity and Specificity

1995
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:4

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Triazoles

1995
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Burns : journal of the International Society for Burn Injuries, 1995, Volume: 21, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts

1995
Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp.
    Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:4

    Topics: Candida; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1994
Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes.
    Toxicology, 1995, Feb-06, Volume: 96, Issue:2

    Topics: Analysis of Variance; Animals; Cell Membrane Permeability; Cells, Cultured; Fluconazole; Ketoconazole; L-Lactate Dehydrogenase; Liver; Lysosomes; Mitochondria, Liver; Neutral Red; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles

1995
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
    Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin

1994
Pneumocystis carinii is resistant to imidazole antifungal agents.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:8

    Topics: Animals; Antifungal Agents; Ergosterol; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Miconazole; Pneumocystis; Rats; Rats, Sprague-Dawley; Triazoles

1994
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:1

    Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies

1994
Ro 09-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:12

    Topics: Animals; Antifungal Agents; Carbon Monoxide; Cholesterol; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fluconazole; Fungal Proteins; Glycine; Heme; Ketoconazole; Liver; Male; Microsomes, Liver; Oxidoreductases; Pyrans; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Sensitivity and Specificity; Sterol 14-Demethylase

1993
Ketoconazole and fluconazole drug interactions.
    Archives of internal medicine, 1994, May-09, Volume: 154, Issue:9

    Topics: Antifungal Agents; Arrhythmias, Cardiac; Astemizole; Drug Interactions; Fluconazole; Humans; Ketoconazole; Terfenadine

1994
Neonatal renal candidiasis.
    Journal of paediatrics and child health, 1994, Volume: 30, Issue:2

    Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Infant; Ketoconazole; Male; Pyelonephritis; Ureteral Obstruction

1994
Severe candidal infections in neutropenic patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2

    Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia

1993
Fluconazole-resistant Candida in AIDS patients. Report of two cases.
    Oral surgery, oral medicine, and oral pathology, 1993, Volume: 76, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Ketoconazole; Male

1993
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1994, Feb-18, Volume: 36, Issue:916

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses

1994
Cost-effective treatment of Candida esophagitis.
    Annals of internal medicine, 1993, May-15, Volume: 118, Issue:10

    Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole

1993
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Drug Therapy, Combination; Encephalitis; Fluconazole; Hemophilia A; Humans; Itraconazole; Ketoconazole; Male; Nitroimidazoles; Transfusion Reaction; Trypanocidal Agents

1993
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
    Genitourinary medicine, 1993, Volume: 69, Issue:2

    Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin

1993
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
    Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Middle Aged; Retrospective Studies; Treatment Outcome

1993
[Strategy for examination and therapy of mycotic keratitis].
    Klinische Monatsblatter fur Augenheilkunde, 1993, Volume: 202, Issue:3

    Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Keratitis; Ketoconazole; Mycoses; Ophthalmic Solutions; Therapeutic Irrigation

1993
Pharmacokinetics of antifungal agents.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1993, Volume: 13 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis

1993
Cost-effective treatment of Candida esophagitis.
    Annals of internal medicine, 1993, May-15, Volume: 118, Issue:10

    Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole

1993
Cost-effective treatment of Candida esophagitis.
    Annals of internal medicine, 1993, May-15, Volume: 118, Issue:10

    Topics: Candidiasis; Drug Costs; Esophagitis; Fluconazole; Humans; Ketoconazole

1993
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine

1995
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1996, Feb-02, Volume: 38, Issue:967

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses

1996
Azole drug resistance in yeasts.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses

1995
Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:2

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results

1996
Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
    Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:2

    Topics: Animals; Antifungal Agents; Antipyrine; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluconazole; Infusion Pumps; Ketoconazole; Liver; Male; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley

1996
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
    Journal of clinical microbiology, 1996, Volume: 34, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results

1996
New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antifungal Agents; Candida albicans; CD4-Positive T-Lymphocytes; Digestive System; Disease Models, Animal; Female; Fluconazole; Ketoconazole; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Nystatin; Oropharynx; Peptides; Peptides, Cyclic

1996
Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Candida; Drug Resistance, Microbial; Fluconazole; Fluorescent Dyes; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rhodamine 123; Rhodamines

1996
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1996, Volume: 47, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests

1996
Rationalizing prescribing for oral and oesophageal candidiasis.
    International journal of STD & AIDS, 1996, Volume: 7, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs; Esophageal Diseases; Fluconazole; Humans; Ketoconazole; Medical Audit; Practice Guidelines as Topic; Retrospective Studies

1996
Inhibition of mitochondrial function in isolated rate liver mitochondria by azole antifungals.
    Journal of biochemical toxicology, 1996, Volume: 11, Issue:3

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Fluconazole; In Vitro Techniques; Ketoconazole; Male; Miconazole; Mitochondria, Liver; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Oxidative Phosphorylation; Rats; Succinate Dehydrogenase

1996
[White piedra. Report of a case].
    Revista medica de Chile, 1996, Volume: 124, Issue:5

    Topics: Adolescent; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Piedra; Scalp Dermatoses; Trichosporon

1996
A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Microbios, 1996, Volume: 87, Issue:352

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Antagonism; Fluconazole; Ketoconazole; Microbial Sensitivity Tests

1996
Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitors.
    Journal of clinical pharmacology, 1997, Volume: 37, Issue:3

    Topics: Adult; Antifungal Agents; Biotransformation; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol Congeners; Ethinyl Estradiol; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Mestranol; Microsomes, Liver

1997
Characterization of Saccharomyces cerevisiae CYP61, sterol delta22-desaturase, and inhibition by azole antifungal agents.
    The Journal of biological chemistry, 1997, Apr-11, Volume: 272, Issue:15

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ergosterol; Fluconazole; Ketoconazole; Oxidoreductases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Spectrophotometry, Atomic; Sterol 14-Demethylase

1997
Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363.
    FEMS microbiology letters, 1997, Feb-15, Volume: 147, Issue:2

    Topics: Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Sterols

1997
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry

1997
Chronic Candida albicans otitis media in children with immunodeficiency.
    The Pediatric infectious disease journal, 1997, Volume: 16, Issue:5

    Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Chronic Disease; Diagnosis, Differential; Female; Fluconazole; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Ketoconazole; Otitis Media, Suppurative

1997
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet

1996
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biological Transport; Candida albicans; Drug Resistance, Microbial; Fluconazole; Genes, Fungal; Genes, MDR; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; RNA, Messenger

1997
Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro.
    Therapeutic drug monitoring, 1997, Volume: 19, Issue:4

    Topics: Adult; Antifungal Agents; Antirheumatic Agents; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Liver; Male; Microsomes, Liver; Middle Aged

1997
Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1997, Volume: 84, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Carcinoma, Squamous Cell; Colony Count, Microbial; Cranial Irradiation; Female; Fluconazole; Humans; Ketoconazole; Logistic Models; Male; Middle Aged; Odds Ratio; Oropharyngeal Neoplasms; Smoking; Statistics, Nonparametric; Xerostomia

1997
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
    International journal of STD & AIDS, 1997, Volume: 8, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies

1997
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1997, Sep-12, Volume: 39, Issue:1009

    Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens

1997
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Pneumonologia i alergologia polska, 1997, Volume: 65, Issue:5-6

    Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum

1997
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1997
Prediction of relapse after treatment of coccidioidomycosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:5

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Cohort Studies; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies

1997
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    AIDS (London, England), 1997, Volume: 11, Issue:15

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole

1997
[Effect of keratin on the efficacy of fluconazole].
    Mycoses, 1997, Volume: 40 Suppl 1

    Topics: Animals; Antifungal Agents; Blood Proteins; Fluconazole; Itraconazole; Keratins; Ketoconazole; Kinetics; Sheep; Skin; Wool

1997
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Mycoses, 1997, Volume: 40 Suppl 1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Recurrence

1997
Effects of three azole derivatives on the lipids of different strains of Sporothrix schenckii.
    Canadian journal of microbiology, 1997, Volume: 43, Issue:12

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Lanosterol; Lipids; Sporothrix

1997
[Evaluation of the E-test: comparison of E-test and microbroth dilution method in azole antifungal susceptibility test].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 1998, Volume: 39, Issue:1

    Topics: Antifungal Agents; Candida albicans; Fluconazole; Indicator Dilution Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results

1998
Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    American journal of veterinary research, 1998, Volume: 59, Issue:2

    Topics: Analysis of Variance; Animals; Antifungal Agents; Aspergillus; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Horse Diseases; Horses; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Natamycin; Penicillium

1998
Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
    International journal of STD & AIDS, 1998, Volume: 9, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Body Weight; Candidiasis; CD4 Lymphocyte Count; Drug Resistance, Microbial; Esophageal Diseases; Female; Fluconazole; Humans; Ketoconazole; Male; Retrospective Studies; Survivors; Treatment Outcome

1998
Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Antifungal Agents; Blastomyces; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1998
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
    Journal of clinical microbiology, 1998, Volume: 36, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1998
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Neoplasms; Pichia; Retrospective Studies; Risk Factors; Slovakia; Treatment Outcome

1998
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1998, Volume: 27, Issue:5

    Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin

1998
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
    Therapeutic drug monitoring, 1998, Volume: 20, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Calcium Channel Blockers; Child; Cyclosporine; Diltiazem; Drug Administration Schedule; Drug Interactions; Fluconazole; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Individuality; Itraconazole; Ketoconazole; Linear Models; Middle Aged

1998
Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1998, Volume: 27, Issue:7

    Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cheek; Epithelial Cells; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Male; Microscopy, Electron, Scanning; Mouth Mucosa; Nystatin

1998
Blastomycosis in dogs: 115 cases (1980-1995).
    Journal of the American Veterinary Medical Association, 1998, Sep-01, Volume: 213, Issue:5

    Topics: Age Distribution; Amphotericin B; Animals; Antibodies, Fungal; Antifungal Agents; Blastomyces; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluconazole; Housing, Animal; Immunodiffusion; Itraconazole; Ketoconazole; Louisiana; Male; Radiography, Thoracic; Retrospective Studies; Seasons; Treatment Outcome

1998
Synergy of nitric oxide and azoles against Candida species in vitro.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazenes

1998
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca

1998
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Archives of oral biology, 1998, Volume: 43, Issue:12

    Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors

1998
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
    Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Azoles; Brazil; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mycology; Prevalence; Prospective Studies; Statistics, Nonparametric

1998
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
    International journal of antimicrobial agents, 1998, Volume: 10, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests

1998
Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
    Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:2

    Topics: Algorithms; Antifungal Agents; Blotting, Western; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; In Vitro Techniques; Intestine, Small; Ketoconazole; Kinetics; Microsomes; Microsomes, Liver; Midazolam; Mixed Function Oxygenases

1999
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Cross Infection; Fluconazole; Hospitals, University; Humans; Incidence; Intensive Care Units; Iowa; Ketoconazole; Medical Records; Postoperative Complications

1999
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts

1999
Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4

    Topics: Antifungal Agents; Azoles; Candida albicans; Cell Division; Drug Resistance, Microbial; Fluconazole; Humans; Ketoconazole; Methionine; Sulfur Radioisotopes

1999
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Oral diseases, 1998, Volume: 4, Issue:4

    Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin

1998
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells

1999
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
    Journal of medical microbiology, 1999, Volume: 48, Issue:7

    Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Clotrimazole; DNA, Fungal; DNA, Mitochondrial; Drug Resistance, Microbial; Econazole; Electrophoresis, Agar Gel; Fluconazole; Humans; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Polyenes

1999
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pathologie-biologie, 1999, Volume: 47, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Female; Fluconazole; France; Fungemia; Hospitals, University; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Postoperative Complications; Saccharomyces cerevisiae

1999
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Mycoses, 1999, Volume: 42, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic

1999
Quantitative drug interactions prediction system (Q-DIPS): a computer-based prediction and management support system for drug metabolism interactions.
    European journal of clinical pharmacology, 1999, Volume: 55, Issue:5

    Topics: Antifungal Agents; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Data Collection; Databases as Topic; Drug Interactions; Enzyme Inhibitors; Fluconazole; Ketoconazole; Mixed Function Oxygenases; Pharmaceutical Preparations

1999
Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Microbiology (Reading, England), 1999, Volume: 145 ( Pt 10)

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Ketoconazole; Molecular Sequence Data; Mutation; Oxidoreductases; Saccharomyces cerevisiae; Sequence Alignment; Sterol 14-Demethylase

1999
[Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1999, Volume: 12, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts

1999
[Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].
    Revue des maladies respiratoires, 1999, Volume: 16, Issue:5

    Topics: Antifungal Agents; Brain; Brain Diseases; Central Nervous System Fungal Infections; Fluconazole; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed

1999
The use of systemic antimycotics in dermatotherapy.
    European journal of dermatology : EJD, 2000, Volume: 10, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea

2000
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results

2000
Inhibitory effect of azole antifungal agents on the glucuronidation of lorazepam using rabbit liver microsomes in vitro.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:5

    Topics: Animals; Anti-Anxiety Agents; Antifungal Agents; Azoles; Binding, Competitive; Detergents; Fluconazole; Glucuronic Acid; In Vitro Techniques; Ketoconazole; Kinetics; Lorazepam; Male; Miconazole; Microsomes, Liver; Rabbits; Uridine Diphosphate Glucuronic Acid

2000
Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Paracoccidioides; Sterols

2000
Quantitative prediction of in vivo drug interactions between nevirapine and antifungal agents from in vitro data in rats.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:9

    Topics: Albumins; Animals; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Fluconazole; Ketoconazole; Male; Microsomes, Liver; Nevirapine; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley

2000
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests

2000
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
    British journal of haematology, 2001, Volume: 112, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Neutropenia; Prospective Studies; Retrospective Studies

2001
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors

2000
Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Vagina

2001
Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:1

    Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Digestive System; Fluconazole; Itraconazole; Ketoconazole; Mice

2001
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1999
Anti leishmanial therapy--the changing scene.
    The Journal of the Association of Physicians of India, 1995, Volume: 43, Issue:3

    Topics: Antifungal Agents; Fluconazole; Humans; Ketoconazole; Leishmaniasis

1995
Treatment for coccidioidomycosis in pregnancy?
    Postgraduate medicine, 2001, Volume: 109, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Erythema Nodosum; Female; Fluconazole; Humans; Ketoconazole; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Risk Factors

2001
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jun-01, Volume: 32, Issue:11

    Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Drug Resistance, Microbial; Female; Fluconazole; HIV-1; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Oropharynx; Pharyngeal Diseases

2001
Candidiasis at ICAAC.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:10

    Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Biological Availability; Candida albicans; Candidiasis, Oral; Clinical Trials as Topic; Drug Resistance, Microbial; Fluconazole; HIV; Humans; Itraconazole; Ketoconazole; Mutation

1995
Histoplasmosis: update 1998.
    AIDS clinical care, 1998, Volume: 10, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dosage Forms; Fluconazole; Histoplasmosis; Itraconazole; Ketoconazole; Remission Induction

1998
[Endemic mycotic infections].
    La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Travel

2001
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2001, Volume: 30, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; China; Cohort Studies; Drug Resistance, Microbial; Ethnicity; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Recurrence

2001
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
    Electrophoresis, 2001, Volume: 22, Issue:12

    Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole

2001
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2001, Volume: 30, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence

2001
[Synthesis and antifungal activity of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1997, Volume: 32, Issue:12

    Topics: Antifungal Agents; Candida albicans; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Saccharomyces; Structure-Activity Relationship; Triazoles

1997
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:2

    Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi

2001
Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia.
    International immunopharmacology, 2001, Volume: 1, Issue:12

    Topics: Acute Disease; Aged; Aged, 80 and over; Antifungal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Clone Cells; Female; Fluconazole; Humans; Interferon-gamma; Interleukin-4; Itraconazole; Ketoconazole; Leukemia, Myeloid; Leukopenia; Lymphocyte Activation; Male; Miconazole; Middle Aged; Neoplastic Stem Cells; T-Lymphocytes

2001
Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
    Folia medica, 2001, Volume: 43, Issue:3

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests

2001
Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
    Memorias do Instituto Oswaldo Cruz, 2002, Volume: 97, Issue:2

    Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Serotyping

2002
Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Time Factors

2002
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Colorimetry; Coloring Agents; Dermatomycoses; Drug Resistance, Fungal; Epidermophyton; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Oxazines; Sensitivity and Specificity; Trichophyton; Xanthenes

2002
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Revista medica de Chile, 2002, Volume: 130, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitors; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

2002
Characterization of quinidine 3-hydroxylation as a probe for the CYP 3A enzyme using a novel capillary electrophoresis technique.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2002, Volume: 16, Issue:4-5

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biomarkers; Cytochrome P-450 CYP3A; Electrophoresis, Capillary; Enzyme Inhibitors; Erythromycin; Fluconazole; Hydroxylation; Ketoconazole; Microsomes, Liver; Oxidoreductases, N-Demethylating; Quinidine; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism

2002
Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations.
    Farmaco (Societa chimica italiana : 1989), 2002, Volume: 57, Issue:11

    Topics: Antifungal Agents; Calibration; Capsules; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Clotrimazole; Densitometry; Fluconazole; Indicators and Reagents; Ketoconazole; Ointments; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet

2002
Prevalence and antifungal susceptibilities of yeast isolates during one year at a university hospital in Turkey.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Fluconazole; Hospitals, University; Humans; Ketoconazole; Microbial Sensitivity Tests; Prevalence; Turkey

2002
Variations in color.
    The Journal of family practice, 2003, Volume: 52, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Black People; Diagnosis, Differential; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Selenium Compounds; Skin Pigmentation; Tinea Versicolor

2003
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole

2003
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
    Revista iberoamericana de micologia, 2003, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt

2003
Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
    Canadian journal of microbiology, 2003, Volume: 49, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Atropine; Bucladesine; Candida albicans; Chromatography, Gas; Cryptococcus neoformans; Cyclic AMP; Drug Synergism; Ergosterol; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Phosphodiesterase Inhibitors

2003
Fungal infection of sutureless self-sealing incision for cataract surgery.
    Ophthalmology, 2003, Volume: 110, Issue:11

    Topics: Aged; Aged, 80 and over; Amphotericin B; Aspergillosis; Candidiasis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Humans; Ketoconazole; Male; Minimally Invasive Surgical Procedures; Natamycin; Phacoemulsification; Retrospective Studies; Scleritis; Surgical Wound Infection; Suture Techniques

2003
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD).
    Mycoses, 2003, Volume: 46, Issue:9-10

    Topics: Acremonium; Aged; Antifungal Agents; Aspergillus; Candida; Child; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Kidney Failure, Chronic; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis

2003
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
    Mycoses, 2003, Volume: 46, Issue:11-12

    Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula

2003
Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2003, Volume: 86, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Ketoconazole; Naegleria; Water Microbiology

2003
[Modern antimycotics. What the treating physician needs to know].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors

2004
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
    Mycoses, 2004, Volume: 47, Issue:3-4

    Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping

2004
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
    Medical mycology, 2004, Volume: 42, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; Critical Care; Drug Resistance, Fungal; Fluconazole; Humans; Inpatients; Intensive Care Units; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

2004
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
    Drug metabolism and drug interactions, 2004, Volume: 20, Issue:1-2

    Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx

2004
CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: Base Sequence; Candida albicans; Cloning, Molecular; Culture Media; DNA-Binding Proteins; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Ketoconazole; Lac Operon; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors

2004
Etest for assessing the susceptibility of filamentous fungi.
    Acta microbiologica et immunologica Hungarica, 2004, Volume: 51, Issue:3

    Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Quality Control; Reproducibility of Results

2004
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Chemotherapy, 2004, Volume: 50, Issue:6

    Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes

2004
[Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:8-9

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Antineoplastic Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies

2004
Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
    Mycoses, 2005, Volume: 48, Issue:3

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Propolis; Terbinafine; Trichophyton; Turkey

2005
Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents.
    Memorias do Instituto Oswaldo Cruz, 2005, Volume: 100, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Peptide Hydrolases

2005
Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:7

    Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Fungi; Humans; Keratitis; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome

2006
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
    Mycopathologia, 2005, Volume: 160, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole

2005
In vitro susceptibility of oral Candida to seven antifungal agents.
    Oral microbiology and immunology, 2005, Volume: 20, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole

2005
Long term control of hypercortisolism with fluconazole: case report and in vitro studies.
    European journal of endocrinology, 2006, Volume: 154, Issue:4

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged, 80 and over; Antifungal Agents; Cell Line, Tumor; Corticosterone; Cushing Syndrome; Female; Fluconazole; Humans; Ketoconazole; Lung Neoplasms; Recurrence

2006
Aureobasidium pullulans keratitis.
    Clinical & experimental ophthalmology, 2006, Volume: 34, Issue:3

    Topics: Ascomycota; Corneal Ulcer; Eye Infections, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Retrospective Studies

2006
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Mycoses, 2006, Volume: 49, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
In vitro methods for antifungal susceptibility testing of Trichophyton spp.
    Mycological research, 2006, Volume: 110, Issue:Pt 11

    Topics: Antifungal Agents; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton

2006
White piedra in children.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Connecticut; Diagnosis, Differential; Female; Fluconazole; Hair; Hair Preparations; Humans; Ketoconazole; Lice Infestations; Male; Mexico; New York City; Piedra; Trichosporon; United Kingdom; Yemen

2006
In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
    Indian journal of medical microbiology, 2006, Volume: 24, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Eye Diseases; Fluconazole; Keratitis; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses

2006
Antifungal activities of azole agents against the Malassezia species.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:3

    Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole

2007
Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.
    Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 97, Issue:1

    Topics: Animals; Antifungal Agents; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Genes, Reporter; Humans; Itraconazole; Ketoconazole; Liver Neoplasms; Luciferases; Mice; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic

2007
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    Archives of dermatological research, 2007, Volume: 299, Issue:2

    Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole

2007
[Oral isolates of Saccharomyces in patients with oral fungal infection and their susceptibility to antifungal drugs].
    Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 2007, Volume: 25, Issue:1

    Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Ketoconazole; Nystatin; Saccharomyces

2007
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:12

    Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole

2007
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
    Mycopathologia, 2007, Volume: 164, Issue:1

    Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine

2007
Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:11

    Topics: Animals; Catalysis; Cells, Cultured; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Inhibitors; Fluconazole; Fluoxetine; Fluvoxamine; Hepatocytes; Ketoconazole; Kinetics; Male; Miconazole; Microsomes, Liver; Midazolam; Phenytoin; Quinine; Rats; Rats, Sprague-Dawley; Tolbutamide

2007
Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection.
    Cancer letters, 2007, Dec-08, Volume: 258, Issue:1

    Topics: Animals; Antifungal Agents; Carcinoma, Hepatocellular; Enzyme Activation; Enzyme Induction; Fluconazole; Itraconazole; Ketoconazole; Liver Neoplasms, Experimental; Mice; NAD; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured

2007
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
    Chemotherapy, 2008, Volume: 54, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole

2008
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
    Revista iberoamericana de micologia, 2007, Dec-31, Volume: 24, Issue:4

    Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Epidermophyton; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Mexico; Microsporum; Onychomycosis; Tinea; Tinea Capitis; Tinea Pedis; Trichophyton

2007
Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis.
    Current drug metabolism, 2007, Volume: 8, Issue:8

    Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Databases, Factual; Drug Interactions; Enzyme Inhibitors; Erythromycin; Fluconazole; Ketoconazole; Midazolam; Substrate Specificity; Verapamil

2007
[Relative bioavailability and bioequivalence of the antimycotics ketoconazole and fluconazole].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:11-12

    Topics: Animals; Antifungal Agents; Biological Availability; Fluconazole; Humans; Ketoconazole; Male; Rabbits; Therapeutic Equivalency

2006
Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.
    The Journal of steroid biochemistry and molecular biology, 2008, Volume: 110, Issue:1-2

    Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fluconazole; Humans; Hydroxylation; Ketoconazole; Lynestrenol; Microsomes, Liver; Norethindrone; Sulfaphenazole

2008
Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
    Mycoses, 2008, Volume: 51, Issue:6

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Middle Aged; Thiophenes; Tinea; Trichophyton

2008
Effect of commonly used herbicides on the virulence factor CDR1 in Candida albicans.
    Environmental toxicology and chemistry, 2008, Volume: 27, Issue:11

    Topics: Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Fungal Proteins; Ketoconazole; Membrane Transport Proteins

2008
Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs.
    Biochemical and biophysical research communications, 2008, Jul-18, Volume: 372, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzaldehydes; Catechols; Cell Membrane; Cell Wall; Drug Resistance, Fungal; Fluconazole; Gene Deletion; Humans; Ketoconazole; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sorbitol; Thymol

2008
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    The Southeast Asian journal of tropical medicine and public health, 2008, Volume: 39, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests

2008
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.
    Scandinavian journal of infectious diseases, 2008, Volume: 40, Issue:11-12

    Topics: Antifungal Agents; Candida albicans; Drug Administration Schedule; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Miconazole; Polyendocrinopathies, Autoimmune

2008
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
    Chemical biology & drug design, 2008, Volume: 72, Issue:3

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole

2008
Fungistatic effects of optical brightener 220 against Trichophyton tonsurans, Aspergillus fumigatus and Candida albicans.
    The Journal of dermatological treatment, 2009, Volume: 20, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cells, Cultured; Culture Media; Fibroblasts; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Risk Factors; Sensitivity and Specificity; Stilbenes; Trichophyton

2009
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciclopirox; Deferiprone; Drug Combinations; Fluconazole; Iron Chelating Agents; Ketoconazole; Microbial Sensitivity Tests; Pyridones

2009
The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport.
    Biochimica et biophysica acta, 2009, Volume: 1788, Issue:9

    Topics: Adenosine Triphosphatases; Amino Acid Sequence; Azides; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Miconazole; Mutagenesis, Site-Directed; Prazosin; Protein Transport; Rhodamines; Saccharomyces cerevisiae; Substrate Specificity

2009
Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
    Microbial drug resistance (Larchmont, N.Y.), 2009, Volume: 15, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Cyclooxygenase Inhibitors; Cysteine; Drug Resistance, Fungal; Fluconazole; Isoindoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Organoselenium Compounds; Proton-Translocating ATPases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins

2009
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole

2009
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole

2009
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
    The new microbiologica, 2009, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole

2009
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
    Journal of pharmaceutical and biomedical analysis, 2009, Dec-05, Volume: 50, Issue:5

    Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole

2009
In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species.
    Mycopathologia, 2010, Volume: 169, Issue:4

    Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Disulfides; Drug Synergism; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Sulfinic Acids

2010
Screening of antimycotics in Swedish sewage treatment plants--waters and sludge.
    Water research, 2010, Volume: 44, Issue:2

    Topics: Antifungal Agents; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Naphthalenes; Sewage; Sweden; Terbinafine; Waste Disposal, Fluid; Water Pollutants, Chemical

2010
Current concepts in systemic and topical therapy for superficial mycoses.
    Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2

    Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Azoles; Dermatomycoses; Drug Administration Schedule; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Tolnaftate; United States

2010
Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010, Volume: 17, Issue:12

    Topics: Antifungal Agents; Candida; Drug Synergism; Erythrocytes; Fluconazole; Humans; Ketoconazole; Ocimum; Oils, Volatile; Plant Extracts

2010
[Malassezia folliculitis: 21 cases].
    Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Dermatomycoses; Female; Fluconazole; Folliculitis; Humans; Ketoconazole; Kidney Transplantation; Malassezia; Male; Middle Aged; Postoperative Complications; Prospective Studies; Renal Dialysis; Risk Factors; Tunisia; Young Adult

2010
In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 334, Issue:2

    Topics: Analgesics, Opioid; Animals; Cattle; Codeine; Dextropropoxyphene; Drug Interactions; Fluconazole; Glucuronosyltransferase; Humans; In Vitro Techniques; Ketoconazole; Methadone; Microsomes, Liver; Models, Biological; Serum Albumin, Bovine

2010
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2010
Evaluation of the origin of a sample of Sporothrix schenckii that caused contamination of a researcher in Southern Brazil.
    Mycopathologia, 2011, Volume: 171, Issue:3

    Topics: Brazil; Fluconazole; Humans; Ketoconazole; Laboratories; Male; Microbial Sensitivity Tests; Potassium Iodide; Random Amplified Polymorphic DNA Technique; Research Personnel; Sporothrix; Sporotrichosis

2011
Ketoconazole and miconazole alter potassium homeostasis in Saccharomyces cerevisiae.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:1

    Topics: Antifungal Agents; Cations; Fluconazole; Glucose; Glucosephosphate Dehydrogenase; Homeostasis; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Miconazole; Nucleotides; Oxygen Consumption; Potassium; Protons; Saccharomyces cerevisiae

2011
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
    Veterinary microbiology, 2011, Aug-26, Volume: 152, Issue:1-2

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
    Mycopathologia, 2011, Volume: 172, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole

2011
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae

2011
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
    Clinical oral investigations, 2012, Volume: 16, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia

2012
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Veterinary microbiology, 2012, Mar-23, Volume: 155, Issue:2-4

    Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
Tolbutamide hydroxylation by hepatic microsomes from Atlantic salmon (Salmo salar L.).
    Molecular biology reports, 2012, Volume: 39, Issue:6

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diclofenac; Dioxoles; Ellipticines; Fish Proteins; Fluconazole; Hydroxylation; Ketoconazole; Kinetics; Lignans; Microsomes, Liver; Oxazines; Salmo salar; Sulfaphenazole; Tolbutamide

2012
Distribution, behavior and fate of azole antifungals during mechanical, biological, and chemical treatments in sewage treatment plants in China.
    The Science of the total environment, 2012, Jun-01, Volume: 426

    Topics: Antifungal Agents; Azoles; Biodegradation, Environmental; China; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical

2012
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    The Kaohsiung journal of medical sciences, 2012, Volume: 28, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
CDR4 is the major contributor to azole resistance among four Pdr5p-like ABC transporters in Neurospora crassa.
    Fungal biology, 2012, Volume: 116, Issue:7

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Knockout Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Phylogeny; Sequence Homology, Amino Acid

2012
Prototheca wickerhamii as a cause of neuroinfection in a child with congenital hydrocephalus. First case of human protothecosis in Poland.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:2

    Topics: Amphotericin B; Antifungal Agents; DNA, Plant; Fluconazole; Head; Humans; Hydrocephalus; Infant; Ketoconazole; Male; Meningoencephalitis; Microscopy, Electron; Molecular Sequence Data; Poland; Prototheca; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Outcome; Ventriculoperitoneal Shunt

2012
Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:10

    Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biofilms; Caco-2 Cells; Candida albicans; Candidiasis; Drug Synergism; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Male; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Triterpenes; Virulence

2012
Fluconazole inhibits human adrenocortical steroidogenesis in vitro.
    The Journal of endocrinology, 2012, Volume: 215, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cortodoxone; Desoxycorticosterone; Fluconazole; Humans; Hydrocortisone; Ketoconazole; Pregnenolone; Progesterone

2012
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole

2013
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2013, Volume: 42, Issue:7

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Case-Control Studies; Colony Count, Microbial; Cross-Sectional Studies; DMF Index; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; Humans; Hydroxyurea; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Saliva; Secretory Rate; Young Adult

2013
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
    Die Pharmazie, 2012, Volume: 67, Issue:12

    Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole

2012
Voriconazole suppresses the growth of Leishmania species in vitro.
    Parasitology research, 2013, Volume: 112, Issue:5

    Topics: Animals; Antiprotozoal Agents; Fluconazole; Inhibitory Concentration 50; Ketoconazole; Leishmania; Parasitic Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2013
Pityriasis versicolor: a case of resistance to treatment.
    International journal of dermatology, 2014, Volume: 53, Issue:2

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea Versicolor; Treatment Failure

2014
Transcription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antifungal Agents; Down-Regulation; Drug Resistance, Fungal; Fluconazole; Fusarium; Gene Expression Regulation, Fungal; Genes, Fungal; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Transcription Factors

2014
Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats.
    Biopharmaceutics & drug disposition, 2014, Volume: 35, Issue:4

    Topics: Animals; Caffeine; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dextromethorphan; Drug Interactions; Fluconazole; Fluvoxamine; Ketoconazole; Losartan; Male; Midazolam; Omeprazole; Rats, Sprague-Dawley

2014
Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Journal of investigative and clinical dentistry, 2015, Volume: 6, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Cells, Cultured; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Mycology; Nephelometry and Turbidimetry

2015
Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Cell Line; Female; Fluconazole; Fungal Proteins; Humans; Immunoblotting; Ketoconazole; Lectins; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Nitroimidazoles; Open Reading Frames; Rifampin

2014
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
    Journal of investigative and clinical dentistry, 2016, Volume: 7, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Nystatin

2016
Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.
    Journal of investigative and clinical dentistry, 2011, Volume: 2, Issue:2

    Topics: Antifungal Agents; Candida glabrata; Chromosomes, Fungal; Copper Sulfate; Culture Media; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Genotype; Hemolysin Proteins; Humans; Itraconazole; Ketoconazole; Metallothionein; Phenotype; Proteome; Virulence; Voriconazole

2011
In vitro anti-yeast activity of chloramphenicol: A preliminary report.
    Journal de mycologie medicale, 2015, Volume: 25, Issue:1

    Topics: Antifungal Agents; Candida; Caspofungin; Chloramphenicol; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pilot Projects; Saccharomyces cerevisiae

2015
Arteether resistance reversal by ketoconazole/fluconazole in rodent malaria parasite Plasmodium vinckei.
    Parasitology research, 2015, Volume: 114, Issue:3

    Topics: Animals; Antifungal Agents; Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Fluconazole; Ketoconazole; Malaria; Mice; Plasmodium

2015
Predicting drug-drug interactions involving multiple mechanisms using physiologically based pharmacokinetic modeling: a case study with ruxolitinib.
    Clinical pharmacology and therapeutics, 2015, Volume: 97, Issue:2

    Topics: Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Digoxin; Drug Interactions; Erythromycin; Fasting; Fluconazole; Humans; Ketoconazole; Models, Biological; Nitriles; Prospective Studies; Pyrazoles; Pyrimidines; Retrospective Studies; Rifampin

2015
Cranial vena cava syndrome secondary to cryptococcal mediastinal granuloma in a cat.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2015, Volume: 56, Issue:4

    Topics: Animals; Antifungal Agents; Antihypertensive Agents; Cat Diseases; Cats; Chylothorax; Cryptococcosis; Enalapril; Fluconazole; Granuloma; Ketoconazole; Male; Rutin; Superior Vena Cava Syndrome; Vena Cava, Superior

2015
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
    BMC oral health, 2015, Mar-20, Volume: 15

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole

2015
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
    Journal of investigative and clinical dentistry, 2016, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocandins; Fluconazole; Hemolysin Proteins; Humans; Ketoconazole; Kuwait; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Sri Lanka; Time Factors

2016
Effects of the association of antifungal drugs on the antimicrobial action of endodontic sealers.
    Brazilian oral research, 2015, Volume: 29

    Topics: Antifungal Agents; Bismuth; Calcium Hydroxide; Candida albicans; Epoxy Resins; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Root Canal Filling Materials; Salicylates; Statistics, Nonparametric

2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole

2015
Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stress.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa

2015
Vba4p, a vacuolar membrane protein, is involved in the drug resistance and vacuolar morphology of Saccharomyces cerevisiae.
    Bioscience, biotechnology, and biochemistry, 2016, Volume: 80, Issue:2

    Topics: Amino Acid Transport Systems, Basic; Amino Acids; Antifungal Agents; Biological Transport; Drug Resistance, Fungal; Fluconazole; Gene Expression; Intracellular Membranes; Ketoconazole; Miconazole; Organelle Shape; Protein Isoforms; Protein Structure, Secondary; Protein Structure, Tertiary; Saccharomyces cerevisiae; Salt Tolerance; Sodium Chloride; Vacuoles

2016
Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.
    Journal of peptide science : an official publication of the European Peptide Society, 2015, Volume: 21, Issue:12

    Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Biofilms; Candida albicans; Cell Proliferation; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Hep G2 Cells; Humans; In Vitro Techniques; Ketoconazole; Plankton

2015
Phytotoxicity of wastewater-born micropollutants--Characterisation of three antimycotics and a cationic surfactant.
    Environmental pollution (Barking, Essex : 1987), 2016, Volume: 208, Issue:Pt B

    Topics: Agriculture; Antifungal Agents; Fertilizers; Fluconazole; Imidazoles; Ketoconazole; Plants; Sewage; Soil; Soil Pollutants; Surface-Active Agents; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical

2016
Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
    Nature, 2016, Feb-25, Volume: 530, Issue:7591

    Topics: Animals; Antifungal Agents; Binding Sites; Candida glabrata; Candidiasis; DNA-Binding Proteins; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Hydrazines; Ketoconazole; Mediator Complex; Mice; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protein Structure, Tertiary; Saccharomyces cerevisiae Proteins; Thiourea; Trans-Activators; Transcription Factors; Transcriptional Activation; Up-Regulation

2016
Exploratory Investigation of the Limiting Steps of Oral Absorption of Fluconazole and Ketoconazole in Children Using an In Silico Pediatric Absorption Model.
    Journal of pharmaceutical sciences, 2016, Volume: 105, Issue:9

    Topics: Adult; Antifungal Agents; Biopharmaceutics; Child; Computer Simulation; Dose-Response Relationship, Drug; Fluconazole; Humans; Ketoconazole; Models, Biological; Mouth Mucosa; Permeability; Solubility

2016
Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Mycoses, 2016, Volume: 59, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Birds; Brazil; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Reservoirs; Environmental Microbiology; Feces; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Typing; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Trees

2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Antifungal Agents; Clotrimazole; Cryptococcus; Enzyme Activation; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Lanosterol; Pyridines; Sterol 14-Demethylase; Tetrazoles; Voriconazole

2016
Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
    Scientific reports, 2016, 06-13, Volume: 6

    Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Cytochrome P450 Family 51; Drug Evaluation, Preclinical; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Kinetics; Lipids; Malassezia; Spectrophotometry; Sterol 14-Demethylase; Sterols; Voriconazole

2016
Unbound liver concentration is the true inhibitor concentration that determines cytochrome P450-mediated drug-drug interactions in rat liver.
    Xenobiotica; the fate of foreign compounds in biological systems, 2017, Volume: 47, Issue:6

    Topics: Animals; Area Under Curve; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Ketoconazole; Kinetics; Liver; Microsomes, Liver; Rats

2017
Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
    Journal de mycologie medicale, 2017, Volume: 27, Issue:2

    Topics: Acyclic Monoterpenes; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Monoterpenes; Mycelium; Spores, Fungal; Terpenes; Tinea; Trichophyton

2017
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:7

    Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyridines; Sterol 14-Demethylase; Substrate Specificity; Tetrazoles; Trichophyton; Voriconazole

2017
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2017, Volume: 67, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Kidney Failure, Chronic; Kidney Transplantation; Microbial Sensitivity Tests; Pakistan; Prevalence; Prospective Studies; Tertiary Care Centers; Voriconazole

2017
Effects of (1
    BioMed research international, 2017, Volume: 2017

    Topics: Chagas Disease; Drug Combinations; Drug Synergism; Fluconazole; Humans; Ketoconazole; Nitroimidazoles; Pentanones; Trypanosoma cruzi

2017
Quantitative prediction of the extent of drug-drug interaction using a physiologically based pharmacokinetic model that includes inhibition of drug metabolism determined in cryopreserved hepatocytes.
    Xenobiotica; the fate of foreign compounds in biological systems, 2018, Volume: 48, Issue:8

    Topics: Animals; Cryopreservation; Drug Interactions; Fluconazole; Hepatocytes; Ketoconazole; Microsomes, Liver; Nifedipine; Rats

2018
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
    Biopharmaceutics & drug disposition, 2018, Volume: 39, Issue:1

    Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software

2018
Pityrosporum folliculitis: A retrospective review of 110 cases.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3

    Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Antifungal Agents; Child; Facial Dermatoses; Female; Fluconazole; Folliculitis; Forehead; Humans; Ketoconazole; Malassezia; Male; Pruritus; Retrospective Studies; Torso; Young Adult

2018
Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
    Medical mycology, 2019, Apr-01, Volume: 57, Issue:3

    Topics: Animals; Antifungal Agents; Azoles; Cytochrome P-450 Enzyme System; Dermatitis; Dermatomycoses; Dog Diseases; Dogs; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Mutation, Missense; Open Reading Frames; Voriconazole

2019
Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
    Veterinary microbiology, 2018, Volume: 220

    Topics: Animals; Antifungal Agents; Bacterial Adhesion; Biofilms; Caenorhabditis elegans; Cat Diseases; Cats; Dermatomycoses; Dog Diseases; Dogs; Epithelial Cells; Fluconazole; Foxes; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence

2018
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
    Anais da Academia Brasileira de Ciencias, 2019, Volume: 91, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts

2019
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
    Xenobiotica; the fate of foreign compounds in biological systems, 2020, Volume: 50, Issue:3

    Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole

2020
The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax.
    Toxicology, 2019, 09-01, Volume: 425

    Topics: Antifungal Agents; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Clotrimazole; Dose-Response Relationship, Drug; Endocrine Disruptors; Fluconazole; Gas Chromatography-Mass Spectrometry; Humans; Inhibitory Concentration 50; Ketoconazole; Miconazole; Steroid 17-alpha-Hydroxylase

2019
Evaluation of the Antifungal Activity of
    Molecules (Basel, Switzerland), 2019, Aug-29, Volume: 24, Issue:17

    Topics: Animals; Antifungal Agents; Arthrodermataceae; Azoles; Candida; Cryptococcus; Drug Combinations; Drug Synergism; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Mentha piperita; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile

2019
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
    Acta dermatovenerologica Croatica : ADC, 2019, Volume: 27, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles

2019
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
    Medical mycology, 2020, Jul-01, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole

2020
The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:7

    Topics: Antifungal Agents; Cyclophosphamide; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological

2020
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Journal de mycologie medicale, 2020, Volume: 30, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole

2020
Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains.
    Mycopathologia, 2020, Volume: 185, Issue:3

    Topics: Animals; Antifungal Agents; Cats; Dogs; Fluconazole; Indicator Dilution Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum

2020
Marked virulence and azole resistance in Candida albicans isolated from patients with periodontal disease.
    Microbial pathogenesis, 2020, Volume: 148

    Topics: A549 Cells; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Ketoconazole; Microbial Sensitivity Tests; Periodontal Diseases; Virulence

2020
Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
    Cancer chemotherapy and pharmacology, 2020, Volume: 86, Issue:5

    Topics: Administration, Oral; Antineoplastic Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Glycine; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Microsomes, Liver; Models, Biological; Pyridines; Rifampin

2020
High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
    PloS one, 2020, Volume: 15, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antitubercular Agents; Candida; Candidiasis; Child; Drug Interactions; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Species Specificity; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Effects of nanoplastic on toxicity of azole fungicides (ketoconazole and fluconazole) in zebrafish embryos.
    The Science of the total environment, 2021, Dec-15, Volume: 800

    Topics: Animals; Azoles; Embryo, Nonmammalian; Fluconazole; Fungicides, Industrial; Ketoconazole; Microplastics; Oxidative Stress; Water Pollutants, Chemical; Zebrafish

2021
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.
    BMC complementary medicine and therapies, 2021, Nov-24, Volume: 21, Issue:1

    Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Plant Extracts; Propolis; Stomatitis, Denture

2021
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
    Mycoses, 2022, Volume: 65, Issue:11

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole

2022
Malassezia species: the need to establish epidemiological cutoff values.
    Medical mycology, 2022, Aug-08, Volume: 60, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole

2022
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
    Medical mycology, 2022, Sep-30, Volume: 60, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Thailand; Tubulin

2022
Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats.
    Veterinary medicine and science, 2023, Volume: 9, Issue:6

    Topics: Animals; Antifungal Agents; Candida; Cats; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth; Yeasts

2023
Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.
    Chemistry & biology, 2007, Volume: 14, Issue:11

    Topics: Animals; Antiprotozoal Agents; Cytochrome P-450 Enzyme Inhibitors; Oxidoreductases; Sterol 14-Demethylase; Substrate Specificity; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis

2007
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
    The Journal of biological chemistry, 2010, Dec-03, Volume: 285, Issue:49

    Topics: Cholesterol; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Host-Pathogen Interactions; Humans; Hydroxylation; Mycobacterium tuberculosis; Oxidation-Reduction; Protein Structure, Tertiary

2010
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Antifungal Agents; Candida; Carbon-13 Magnetic Resonance Spectroscopy; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Thiazolidines

2017
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
    Journal of medicinal chemistry, 2018, 05-10, Volume: 61, Issue:9

    Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells

2018
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
    Bioorganic & medicinal chemistry, 2018, 07-23, Volume: 26, Issue:12

    Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Resistance, Fungal; Drug Stability; Fluconazole; Fungal Proteins; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Isoforms; Sterol 14-Demethylase; Sterols; Structure-Activity Relationship; Triazoles

2018
Design, synthesis and bio-evaluation of C-1 alkylated tetrahydro-β-carboline derivatives as novel antifungal lead compounds.
    Bioorganic & medicinal chemistry letters, 2020, 02-01, Volume: 30, Issue:3

    Topics: Alkylation; Amphotericin B; Antifungal Agents; Candida; Carbolines; Cell Survival; Cryptococcus neoformans; Drug Design; Drug Synergism; Fluconazole; HEK293 Cells; Humans; Kinetics; Microbial Sensitivity Tests; Structure-Activity Relationship

2020
Design, synthesis and evaluation of hydrazine and acyl hydrazone derivatives of 5-pyrrolidin-2-one as antifungal agents.
    Bioorganic & medicinal chemistry letters, 2020, 07-01, Volume: 30, Issue:13

    Topics: Antifungal Agents; Drug Design; Fungi; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidinones; Structure-Activity Relationship

2020
Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives.
    European journal of medicinal chemistry, 2021, Nov-15, Volume: 224

    Topics: Antifungal Agents; Drug Design; Humans; Molecular Structure; Structure-Activity Relationship

2021
Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungi.
    European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

    Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Fluconazole; Fungicides, Industrial; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiophenes

2021
Relaxed Substrate Requirements of Sterol 14α-Demethylase from
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: 14-alpha Demethylase Inhibitors; Ligands; Naegleria fowleri; Sterol 14-Demethylase; Substrate Specificity

2021
Novel Aryl Alkamidazole Derivatives as Multifunctional Antifungal Inhibitors: Design, Synthesis, and Biological Evaluation.
    Journal of medicinal chemistry, 2022, 11-10, Volume: 65, Issue:21

    Topics: Antifungal Agents; Drug Design; Microbial Sensitivity Tests; Structure-Activity Relationship

2022